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ABSTRACT 
Background: The prevalence of obesity and obesity- related disorders, including type 2 
diabetes and non-alcohol fatty liver disease is alarmingly high. These conditions can mostly be 
attributed to increased intake of energy dense food and decreased physical activity. It is also 
proposed that the obesogenic effect of a unfortunate diet is influenced by protein source. There 
is disagreement in defining the best way to deflect the obesity trend; however, most people 
agree that dietary changes and/or exercise are crucial in the treatment of obesity and its related 
disorders. Whether it is the effect of exercise or diet that is essential, is highly debated. 
Furthermore, little is known about the impact of various protein sources in terms of weight loss. 
Methods: Male C57BL/6J BomTac mice were fed a high fat – high sucrose diet with casein, 
salmon and entrecôte for seven weeks to promote obesity. Weight loss was induced by changing 
to either a low fat diet with salmon or entrecôte, exercise with continuous high fat – high sucrose 
feeding or with a combination of a low fat diet and exercise. We evaluated the effect of exercise 
and a low fat diet with different protein sources on weight loss, body composition, glucose 
homeostasis and hepatic gene expression. Body composition was determined by MRI scan prior 
to, in the middle and at the end of the experiment. Glucose tolerance test and insulin tolerance 
test were performed to evaluate glucose homeostasis and insulin sensitivity. Real time qPCR 
was conducted to analyze relative gene expression in terms of fat accumulation and fatty acid 
oxidation in the liver.  
Results: Obesity was induced and insulin sensitivity was impaired when 2/3 of casein was 
replaced with salmon and entrecôte in a high fat – high sucrose diet. Exercise was not of 
significance in terms of weight loss in mice fed high fat – high sucrose diet, but a low fat diet 
reduced body weight and exercise decreased it further. A low fat diet and exercise intervention 
for 5 weeks decreased fat mass and increased lean mass. Glucose tolerance and insulin 
sensitivity were improved by low fat diet and the combined treatment of low fat diet and 
exercise. Mice fed low fat diet with salmon had generally a higher expression of genes involved 
in fatty acid oxidation and lower expression of genes involved in fat accumulation compared to 
the mice fed a low fat diet with entrecôte.  
Conclusion: A mixture of meat, fish and casein proteins promote obesity compared to proteins 
solely from casein. A low fat diet combined with exercise has beneficial effects in terms of 
weight loss, body composition and insulin sensitivity. Low fat diet alone improve plasma 
glucose levels and expression of genes involved in fat accumulation and fatty acid oxidation. 
The importance of protein source in a low fat diet seem insignificant with the exception of 
relative gene expression in the liver, where mice fed salmon exerts beneficial effects. 
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1.0 INTRODUCTION  
1.1 Overweight and obesity 
Overweight and obesity are defined as an unusual or excessive fat accumulation that represents 
a major risk factor for a number of chronic diseases (WHO, 2012).  Body mass index (BMI) is 
a widely used index to classify overweight and obesity in adults. It is defined as weight in 
kilograms divided by the square of height in meters (kg/m2). World health organization (WHO) 
classify overweight as a BMI equal to or greater than 25, whereas a BMI greater than or equal 
to 30 is considered obesity. As BMI is the same for both sexes and for all ages of adults, it 
provides a valuable population based information about overweight and obesity. However, BMI 
does not consider a person’s lean mass and neither does it consider fat distribution (Doherty et 
al., 2014). To obtain information about the distribution of body fat, methods such as waist 
circumference or waist – hip ratio are more appropriate measures for obesity (Observatory, 
2009). A number of studies have indicated that measurements of visceral fat or central obesity 
may be a better predictor of obesity- related disorders than BMI (Wang et al., 2005, Schneider 
et al., 2007, Lee et al., 2008). This may be due to the fact that visceral fat is more likely to cause 
health complications compared to subcutaneous fat. Nevertheless, these methods also have 
limitations and in order to better identify individuals with increased risk of obesity-related 
disorders, an assessment of both general and central obesity should be applied (Observatory, 
2009). 
 
1.1.1 Prevalence of overweight and obesity 
The prevalence of obesity has nearly doubled worldwide since 1980, and in many European 
countries the prevalence have tripled (WHO, 2012). In 2013, the number of overweight and 
obese individuals worldwide had reached 2.1 billion (Ng et al., 2014). The proportion of 
overweight and obese men has increased to 36.9%, while the proportion of women has 
increased to 38%. To define overweight and obesity as a problem concerning only developed 
countries is no longer valid, as the prevalence is increasing more rapidly in middle- and low 
income countries (WHO, 2012). Today, overweight and obesity are linked to more deaths 
worldwide than underweight, where 65% of the world’s population live in countries where 
overweight and obesity is causing more deaths than underweight. Simultaneously, the 
prevalence of childhood obesity is rising, in both developed and developing countries (Ng et 
al., 2014). In 2013, the prevalence of overweight and obesity in developed countries was 23.8% 
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for boys and 22.6% for girls. Furthermore, in developing countries, 12.9% of the boys and 
13.4% of the girls were overweight or obese. In Norway, the average body weight has increased 
by 6 kg from 1985-2008 (Folkehelseinstituttet, 2012), where the greatest increase was among 
young men. Results from the child growth study in Norway indicates that 16% of 8 year olds 
were overweight or obese in 2012 (Folkehelseinstituttet, 2013).  
 
1.1.2 Factors contributing to overweight and obesity 
The main cause of obesity and overweight is an energy imbalance between calories consumed 
and calories expended (WHO, 2012). During the last decades, the food production has evolved 
from self-sufficient farming to processed industrialized food, containing high amounts of fat, 
sugar and salt (FAO, 2013). A possible environmental factor contributing to overconsumption 
of calories is the wide variety and availability of these energy dense foods (Hill et al., 2003). 
Additionally, other environmental factors seem to reduce total energy expenditure due to 
decreased physical activity. Factors contributing to reduced physical activity are among others 
the reductions in jobs requiring physical labor, decreased energy expenditure at school and in 
daily living, as well as an increase in time spend on sedentary activities. However, in addition 
to energy imbalance, genetic factors can affect the development of overweight and obesity on 
many levels, including appetite regulation and energy metabolism as well as hereditary traits 
(Walley et al., 2006).  
 
1.1.3 The pathophysiology of overweight and obesity 
Overweight and obesity is a major cause for a variety of human diseases, including 
cardiovascular disease, type 2 diabetes and cancer (Eyre et al., 2004). Increased body fat, and 
possibly specific depots of body fat are clearly associated with an increased risk of type 2 
diabetes and cardiovascular disease (Goran et al., 2003). Insulin resistance is a major 
characteristic of type 2 diabetes and is causally related to obesity (Kahn, 1994). There are 
evidence that obesity is a low grade chronic inflammatory state, where especially adipose tissue 
inflammation is closely linked to obesity-induced insulin resistance (Weisberg et al., 2003, 
Wellen and Hotamisligil, 2005). Furthermore, non-alcoholic liver disease (NAFLD) often co-
occur with insulin resistance (Farese et al., 2012), and both of these diseases are strongly 
associated with inflammation (Glass and Olefsky, 2012). This indicates that inflammation and 
lipid accumulation in other areas than adipose tissue may be of importance in the development 
of insulin resistance.  
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1.2 The adipose tissue 
The adipose organ consists of both white (WAT) and brown (BAT) adipose tissue. While WAT 
mainly functions as a lipid storage used for fuel between meals, brown adipocytes consume 
lipids to produce heat.  
 
1.2.1 White adipose tissue 
White adipocytes are spherical, unilocular adipocyte cells that vary in size, where the size of 
the adipocyte is mainly determined by the size of the lipid droplet (Cinti, 2009). The lipid 
droplet is mainly comprised of triacylglycerol (TAG) which accounts for most of the cell’s 
volume. In addition to function as an energy storage, WAT has also been recognized as a major 
endocrine and signaling organ (Trayhurn et al., 2008). White adipocytes secrete a large number 
of adipokines that enables extensive crosstalk within adipose tissue and with other tissues, 
including adiponectin, leptin, interleukin 6 (IL-6), monocyte chemotactic protein 1 (MCP-1) 
and tumor necrosis factor alfa (TNF-α). Obesity alters the metabolic and endocrine function of 
adipose tissue, which implies an increased production of proinflammatory molecules and acute 
phase proteins from macrophages (Weisberg et al., 2003). The elevated production of 
proinflammatory adipokines induces chronic inflammation, which seems to be highly 
associated with, if not causative of, insulin resistance (Xu et al., 2003). The macrophage 
infiltration is also linked to increased BMI and adipocyte size (Weisberg et al., 2003, Cancello 
et al., 2005). Furthermore, proinflammatory molecules such as inducible nitric oxide (iNOS) 
and TNF-α have been implicated in the development of insulin resistance (Perreault and 
Marette, 2001, Sartipy and Loskutoff, 2003).  
 
1.2.2 Brown adipose tissue 
In brown adipocytes, TAG’s are stored in the form of multiple small vacuoles, making them 
multilocular adipocytes (Cinti, 2009). The most characteristic organelles of these cells are the 
large, spherical mitochondria, which are highly represented in the cytoplasm. Brown adipocytes 
use energizing substrates to produce heat through non-shivering thermogenesis. This process 
can increase energy expenditure and is activated through the uncoupling of oxidative 
metabolism from Adenosin-5’-triphospat (ATP) production, accompanied by mitochondrial 
uncoupling protein-1 (UCP1). UCP1 is located in the inner mitochondrial membrane of brown 
adipocytes and catalyzes a leak of protons across the inner membrane, dissipating the 
electrochemical gradient that is necessary for ATP- production (Krauss et al., 2005). The 
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metabolic activity of BAT s is regulated through the release of catecholamines by sympathetic 
nerve terminals, acting on β-adrenic receptors located on the surface of brown adipocytes (Wu 
et al., 2013). This binding initiates signaling cascades including cyclic-adenosine 
monophosphate (cAMP) and protein kinase A (PKA), which further phosphorylates and 
activates hormone sensitive lipase (HSL) which cleaves TAG into free fatty acids (FFAs) 
(Townsend and Tseng, 2012). FFAs are transported into the mitochondria and used for β-
oxidation or UCP1 thermogenesis. Numerous of studies demonstrates that UCP1 is found 
exclusively in brown adipocytes (Cannon et al., 1982, Cinti et al., 1989, Ricquier et al., 1991, 
Cannon and Nedergaard, 2004, Frontini et al., 2007), however, Wu et al. (2013), mentions that 
UCP1 is highly selective for both brown and beige adipose cells (Wu et al., 2013). In the 
condition of a positive energy balance and obesity, BAT undergoes changes, in which the brown 
adipocytes gradually morph into cells similar to WAT (Cinti, 2009). These changes include the 
transformation of the lipid depot from multilocular to unilocular. 
 
1.2.3 Occurrence of brown adipose tissue   
In mammals and infants, brown adipocytes are most numerous in the anterior subcutaneous, 
mesenteric and retroperitoneal adipose depots (Cinti, 2009). Primarily, BAT is known for its 
ability to maintain body temperature in newborns without shivering. Although the need for 
BAT is higher in newborns, the application of positron emission tomography (PET) has 
revealed metabolically active BAT in human adults (Hany et al., 2002, Gelfand et al., 2005). 
However, the detection of UCP-1 positive brown adipocytes in human BAT is quite recent 
(Cypess et al., 2009, van Marken Lichtenbelt et al., 2009, Virtanen et al., 2009, Zingaretti et al., 
2009), and have rekindled a interest in human adipose tissue biology for its potential role in 
obesity prevention and treatment.  
 
1.2.4 Transcriptional development of brown and beige adipocytes 
In adipose tissue, the relative amount of white, brown and mixed areas are genetically 
programmed and depends on several factors, including age, environmental temperature and 
nutritional status (Cinti, 2009). Until the identification of a cold induced PPARγ – binding 
partner, peroxisome proliferator-activated receptor gamma coactivator 1 (now PGC-1α), the 
molecular basis for the BAT program has remained unknown (Puigserver et al., 1998). PGC-
1α is activated by a pathway downstream from the β-adrenic receptor (Herzig et al., 2001) and 
is mostly expressed in tissues with a high oxidative metabolism, including liver, kidney and 
muscle (Lin et al., 2005). PGC-1α regulates thermogenesis by inducing the expression of UCP1 
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and is identified as a regulator of brown fat development and function (Wu et al., 2013). Another 
transcriptional factor more present in classical BAT relative to WAT is PRDM16, which seems 
to be necessary for the brown fat phenotype and is effective in browning of visceral fat under 
the stimulation of adrenoreceptors (Seale et al., 2007). Although the majority of brown and 
white adipose depots have different anatomical locations, multilocular UCP1 positive cells exist 
within certain areas of WAT. These cells become more prominent upon prolonged cold 
exposure (Young et al., 1984, Loncar et al., 1986) and when treated with β3- adrenergic receptor 
agonists (Cousin et al., 1992). These so called beige or brite adipocytes can develop from 
transformation of differentiated white adipocytes, de novo differentiation or a combination of 
these phenomena (Cinti, 2009). Cinti and colleagues concluded that the cold- induced browning 
of WAT was most likely caused by transdifferentiation of mature white adipocytes. Brown 
adipocytes in the intrascapular and perirenal depots arise from similar precursors as skeletal 
muscle, which implies a Myf5+ - derived cell lineage (Seale et al., 2008, Sanchez-Gurmaches 
et al., 2012). In contrast, the beige UCP1+ adipocyte cells found in WAT under prolonged β-
adrenic stimulation originates from a non – Myf5- derived cell lineage. These findings suggest 
that the brown fat cells detected in WAT are from a different cell linage than classical brown 
adipocytes and a hypothesis for the origin of the different fat cells is illustrated in Figure 1.1.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Origins of fat cells. At least three types of precursors give rise to white, beige and brown adipose 
cells separately. Precursors for brown adipocytes developmentally originate from dermomyotome and express 
Pax7 and Myf5. White and beige arise from two distinct populations of precursors of Pax\ and Myf5-negative 
lineages. While PPARγ is essential for adipogenesis of all fat cells, various transcriptional components play 
different roles in the development, commitment and differentiation of white, beige and brown fat, and PRDM16 
has been shown to play an important role in regulating both brown and beige fat. Figure is adapted from (Wu et 
al., 2013). 
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1.3 Possible pathogenic effects of obesity on the liver 
The liver plays a major role in regulating metabolism, and is therefore a target for numerous 
metabolic disorders (Burra, 2013). NAFLD increases worldwide and is recognized by a 
spectrum of chronic liver diseases, ranging from hepatic fat accumulation to more serious 
conditions such as cirrhosis and cancer (Maheshwari and Thuluvath, 2011). The metabolic 
syndrome, obesity, hyperlipidemia and type 2 diabetes are closely linked to NAFLD, and 
insulin resistance seems to play a relevant role in the pathogenesis of this disease. The hepatic 
accumulation of lipids is associated with the buildup of neutral lipids as TAGs and cholesterol 
esters in lipid droplets of hepatocytes (Farese et al., 2012). Besides neutral lipids, others lipids 
and their metabolites, including fatty acids (FAs) ceramides and diacylglycerols (DAG) often 
accumulate in the liver. These lipids are known to be potentially bioactive and could therefore 
interfere with hepatocyte function and subsequently reduce the ability to respond to changes in 
insulin levels. In insulin resistant hepatocytes, the insulin stimulated signal transduction 
pathway that suppresses hepatic glucose production is impaired (Haas and Biddinger, 2009). 
However, whether insulin resistance is a cause or a consequence of NAFLD is a debated 
question that needs further investigation. Figure 1.2 illustrates development of fatty liver in the 
setting of insulin resistance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Mechanisms for development of fatty liver in the setting of insulin resistance. In the setting of insulin 
resistance, there is increased adipose tissue hormone-sensitive lipase activity that results in enhanced lipolysis and 
increased non – esterified fatty acid (NEFA) delivery to the liver. NEFAs are preferentially esterified to 
triglycerides. Additionally, hyperinsulinemia leads to increased sterol regulatory element binding protein (SREBP) 
expression, resulting in de novo lipogenesis (DNL) and decreased FA oxidation. Carbohydrate response element-
binding protein (ChREBP) is induced by hyperglycaemia and leads to further increases in DNL. Decreased hepatic 
lipid transport may also occur, in part via altered synthesis of apolipoprotein B, leading to decreased very low-
density (VLDL) production. Figure adapted from (Harrison and Day, 2007). 
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1.4 Weight reduction and prevention of obesity  
1.4.1 Macronutrients  
Although many underlying factors may contribute to obesity, the main cause is an imbalance 
between energy intake and energy expenditure over a prolonged period. The unfavorable diet 
consumed in large parts of the world is energy dense and consists of high amounts of saturated 
FAs (SFAs) and refined carbohydrates, including sucrose. An elevated amount of sucrose in 
the diet is associated with an increased feed efficiency and accumulation of WAT (Hao et al., 
2012). By introducing more carbohydrates in the diet, the intake of dietary protein has been 
reduced, especially compared with typical stone age and hunter- gatherer diets (Cordain et al., 
2000, Cordain et al., 2005). Furthermore, the elevated level of SFAs and n-6 polyunsaturated 
fatty acids (PUFAs) in the diet, compromise the intake of n-3 PUFA, which also represent an 
unfortunate turn in the macronutrient composition. In addition to a more sedentary lifestyle, 
these changes in macronutrient composition may contribute to the high prevalence of obesity 
and type 2 diabetes. The optimal distribution of macronutrients is highly debated, with each 
composition representing its pros and cons. Nevertheless, there is a certain consensus in the fact 
that the amount of protein should not be reduced, while the optimal amount of fat and 
carbohydrates in the diet are still debated. The Norwegian health authorities recommend a diet 
consisting of 45 – 60 E% from carbohydrates, 25 – 40 E% from fat and 10 – 20% from protein 
(Helsedirektoratet, 2014), which can be referred to as a low fat (LF) diet.     
 
1.4.2 Low fat diets  
LF diets are based on the restriction of dietary fat, and Norwegian health authorities especially 
recommend to reduce intake of SFAs and trans FAs (Helsedirektoratet, 2014). Limiting the 
amount of dietary fat is an efficient way to reduce calorie intake, as fat is the most energy dense 
macronutrient (9 kcal/g). In obese individuals, a LF diet has the ability to reduce weight and fat 
mass, as well as improving plasma cholesterol levels (Wood et al., 1991, Stefanick et al., 1998). 
Furthermore, a LF diet has a higher potential than a 70% energy restricted high fat (HF) diet to 
improve insulin sensitivity in obese mice (Muurling et al., 2002). However, compared to diets 
high in protein, LF diets have been observed to promote a higher feed intake (Sorensen et al., 
2008). Nonetheless, a LF diet does not have to compromise the recommended intake, 10 – 20 
E% protein.   
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1.4.3 Exercise  
In addition to specific dietary – advices, Norwegian health authorities recommend children and 
youth to be physically active at least one hour per day and adults is recommended to have either 
a moderate activity level of 150 minutes or a level of high intensity 75 minutes per week 
(Helsedirektoratet, 2014). These suggestions are based on the well-established fact that physical 
activity promotes health, gives surplus and is an important factor in the prevention and 
treatment of several different diagnoses and conditions. Physical activity is an overarching term, 
which, among others include exercise. Whether we discuss physical activity or exercise, it is 
the most variable and thus most determinative component of total energy expenditure (Hunter 
et al., 1998). For this reason, exercise is an important tool during weight loss, and is proposed 
as an effective intervention for both treatment and prevention of type 2 diabetes and obesity 
(Knowler et al., 2002). Furthermore, exercise may have a beneficial impact on the liver, as it 
enhances the expression of a metabolite β- aminoisobutyric acid (BAIBA) derived from PGC-
1α, which results in increased hepatic β-oxidation trough a PPAR-α mediated mechanism 
(Roberts et al., 2014). In addition, BAIBA increases the expression of brown adipocyte-specific 
genes in WAT, which may increase energy expenditure. One study demonstrates that PGC-1α 
stimulates energy expenditure trough increased expression of Fndc5, a muscle- gene product 
that is secreted as a hormone named irisin (Bostrom et al., 2012). Results from the latter study 
hypothesize that irisin activates changes in the subcutaneous adipose tissue by induce browning 
and increase the expression of UCP1.  
 
1.4.4 The effect of protein on satiety, energy expenditure and glucose metabolism 
The amount of dietary protein seems to make a difference in relation to weight loss (Skov et 
al., 1999). There is evidence that protein is more satiating than carbohydrate and fat, and that 
the satiating effect can differ between protein sources (Westerterp-Plantenga, 2008). The 
satiating effect of protein could possibly be due to protein metabolism, higher diet-induced 
thermogenesis or an elevated concentration of the satiety hormones ghrelin and glucagon-like 
peptide 1 (Hall et al., 2003, Lejeune et al., 2006). The elevated diet- induced thermogenesis 
from protein (20–30 %) compared to carbohydrates (5-10 %) and fat (0-3 %) (Tappy, 1996) 
may be mediated by a high consumption of ATP during postprandial protein synthesis (Tessari 
et al., 2003). Additionally, amino acid (AA) oxidation may be of importance, although this 
depends on the protein source (Mikkelsen et al., 2000). The protein source, hence, the AA 
composition, may be an important determinant of the metabolic efficiency as the oxidative 
properties of amino acids vary (Tessari et al., 2003). Furthermore, an increased protein intake 
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has been associated with higher resting metabolic rate and elevated sleeping metabolic rate, 
indicating that protein affects energy expenditure (Whitehead et al., 1996, Mikkelsen et al., 
2000).  
 
High protein (HP) diets have the ability to increase de novo synthesis of glucose from 
gluconeogenic precursors, mainly in the liver (Azzout et al., 1984). An elevated protein intake 
increases the activity of hepatic phosphoenolpyruvate carboxykinase (PEPCK) in both a fasted 
and fed state, and the activity of glucose- 6 phosphatase (G6Pase) is up regulated in fasted state 
and down regulated in fed state (Azzout-Marniche et al., 2005). This suggests that liver 
gluconeogenesis is stimulated by a HP diet; however, in a fed state the newly synthesized 
glucose -6 phosphate (G6P) is directed towards glycogen storage, whereas in fasted state G6P 
is converted to glucose and released from the liver. The activity control of PEPCK and G6Pase 
have a beneficial effect on hepatic metabolism and glucose homeostasis (Trinh et al., 1998) and 
the satiating effect of HP diets could be attributable to improvement of glucose homeostasis 
through enhanced hepatic gluconeogenesis. Protein sources vary in their AA composition as 
well as their distribution of fat following the protein source. Based on these variations, protein 
sources may affect the liver differently, as the distribution between n-3 and n-6 FAs following 
the protein source may differ, and a low n-3/n-6 ratio is associated with NAFLD (Zelber-Sagi 
et al., 2007).     
 
In fat following protein sources, the n-3/n-6 FA ratio differ, where marine protein sources 
commonly have higher levels of n-3 FAs than vegetable and animal protein sources. However, 
as the amount of vegetable oil in fish-feed seems to increase at the expense of fish oil; this alters 
the distribution of the n-3/n-6 ratio in fish (Liland et al., 2013, Midtbo et al., 2015). In Norway, 
this issue is particularly relevant for farmed salmon. Within ten years (1997 – 2007), the amount 
of fish oil in farmed salmon has been halved (Tacon and Metian, 2008), which further reflects 
a reduction in n-3 FAs. Thus, an altered n-3/n-6 FA ratio makes the commercial salmon fillets 
more similar to other protein sources, including meat, when evaluating the FA composition.  
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1.5 Introduction to the study 
In today’s society, weight reduction and maintenance of lean mass is a highly relevant topic. 
Whether it is the effect from exercise or from different dietary approaches that is crucial for 
weight regulation, is a continuously addressed question with contradicting answers. Diets high 
in protein and/or low in carbohydrate have lately gained much attention as a possible method 
for weight reduction. A review from Westerterp-Plantenga suggests that an elevated protein 
intake plays a key role in relation to weight loss, body composition and increased energy 
expenditure (Westerterp-Plantenga, 2008). LF diets have also demonstrated vigorous effects 
regarding weight loss (Stefanick et al., 1998, Vieira et al., 2009). Nevertheless, energy 
expenditure related to physical activity is the most variable factor in energy expenditure  and 
has the greatest potential for increasing total energy expenditure (Hunter et al., 1998). 
Furthermore, a study done on obese women, demonstrates that exercise minimizes the insulin 
resistance that may occur with a sedentary lifestyle (Houmard et al., 2004). Thus, the benefits 
of a healthy diet combined with the advantages of exercise seem useful in the prevention and 
treatment of obesity and its related disorders.  
 
It is known from both literature and studies done in our research group, that different protein 
sources have different obesogenic potential. Some studies demonstrate that marine protein 
sources can attenuate high fat diet-induced obesity (Liaset et al., 2009, Tastesen et al., 2014). 
Despite a similar energy intake, mice fed cod/scallop had lower feed efficiency than mice fed 
chicken, which was subsequently reflected by a reduced adipose tissue mass after seven weeks 
of feeding (Tastesen et al., 2014). These studies were conducted to address the effect of various 
protein sources in diets that promoted obesity; however, less is known about different protein 
sources and their effect to reverse obesity.  
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1.6 Aims of the study  
The present study was conducted to evaluate the importance of dietary macronutrient 
composition, protein source and exercise on obesity development and glucose homeostasis in 
obesity prone C57BL/6J mice. In light of the discovery that casein based diets attenuate obesity 
development, we wanted to evaluate if casein proteins had the same protective effects when 2/3 
of the casein proteins were replaced with a mixture of salmon and entrecôte in the first part of 
the experiment. In the second and main part of the experiment we wanted to compare proteins 
from salmon and entrecôte in a low fat diet and evaluate their effect on reversing diet-induced 
obesity. Additionally, we wanted to investigate the importance of exercise in reversing diet-
induced obesity, and compare it with the impact of a low fat diet with different protein sources.  
 
In this study, we aimed to investigate following:  
- Initially, how a mixture of proteins from casein, salmon and entrecôte affects diet-
induced obesity and glucose homeostasis compared with a 100% casein based HF/HS 
diet.  
- Secondly, the effect of exercise and LF diet with different protein sources on weight 
loss and changes in body composition 
- Thirdly, the importance of diet, exercise and dietary protein source in relation to glucose 
tolerance and insulin sensitivity.  
- Lastly, the effect of exercise and LF diets with different protein sources on expression 
of genes involved in fat accumulation and fat oxidation in the liver.  
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2.0 MATERIALS AND METHODS  
2. 1 The animal experiment 
The mouse model (C57BL/6J BomTac) used in this experiment was selected based on its ability 
to develop obesity, hyperglycemia and hyperinsulinemia when fed a high fat (HF) diet (Black 
et al., 1998). Furthermore, when C57BL/6J mice are fed a low fat (LF) diet, they maintain a 
low fat mass (Petro et al., 2004).  
 
 
 
 
 
 
 
 
Figure 2.1: Private photo of a C57BL/6J mouse from the experiment.  
 
Seventy male mice from the inbred strain C57BL/6J were purchased from Taconic Europe 
(Ejby, Denmark) at eight weeks of age. Upon arrival, all mice were acclimatized for five days 
(29.3 ± 0.4 °C) and fed a LF-diet (Appendix I, Table A.1). The experiment encompassed 60 
mice (n = 10/group) who were assigned to different experimental groups based on body weight 
(BW), lean mass and fat mass, followed by seven weeks fed a HF/HS diet (Appendix I, Table 
A.2) to induce obesity. The mice received three different experimental diets (Appendix I, Table 
A.2), of which two groups received a LF salmon diet, two groups a LF entrecôte diet and two 
groups remained on a HF/HS diet. In each diet, one group received a running wheel. Several 
tests were performed during the experiment, including collection of feces, intraperitoneal 
glucose tolerance test (IPGTT), glucose stimulated insulin secretion (GSIS) and insulin 
tolerance test (ITT). The mice were fed experimental diets for seven weeks prior to termination.  
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2.1.1. Ethical statement  
The animal handling and experiments were performed in accordance with local institutional 
recommendations. The animal experiment was approved by The Norwegian Animal Health 
Authorities (ID number FOTS: 5358).   
 
2.1.2 Preparation of diets  
Casein used in the diets was bought from SIGMA (lot number BCBF8389V). Entrecôte was 
obtained from H. Brakstad Eftf. AS meat processing and salmon was a gift from Marine 
Harvest. The protein sources (entrecôte and salmon) were warm - treated, freeze-dried and 
homogenized at NIFES. Diets were made by weighing the different ingredients on a Mettler 
Toledo PG42002-S/PH weight, mixed together in a Crypto Peerless EF20 blender and further 
stored at -20°C. Distribution of macronutrients in the diets are illustrated in Figure 2.2 as energy 
percent (E%). For a detailed diet composition, see appendix I Table A.2.  
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Distribution of macronutrients in the HF/HS and LF diet (E%).  
 
2.1.3 Diets  
The six groups (n = 10) were given three different diets, presented in Figure 2.3. Three of the 
groups received a running wheel and where therefore assigned to voluntary exercise (Ex). The 
groups with no running wheel are termed sedentary (Sed). Two groups received a LF diet which 
consisted of salmon + casein as protein sources, and two groups were given entrecôte + casein. 
The two remaining groups continued on a HF/HS diet with casein, salmon and entrecôte as 
protein sources.  
H F /H S
3 8 ,8 %
1 4 ,5 %
2 8 ,4 %
1 8 ,3 %
L F
1 6 ,5 %
1 5 ,2 %
8 %
6 0 ,3 %
F a t P ro te in  S u c ro s e S ta rc h
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      Group 1             Group 2          Group 3           Group 4            Group 5              Group 6 
 
Figure 2.3: Grouping, physical activity, diets and protein sources in the experiment.   
 
2.1.4 Housing and feeding 
All mice were individually caged (Techniplast 1291) in a controlled environment throughout 
the experiment. The cages (20 x 36 x 18 cm) were equipped with a house, nesting material, 
wooden bedding and a chewing stick. In addition, the Ex- groups had a running wheel (Fast 
Trac, Bio Serv or ENV – 044, Low Profile Wireless Running Wheel for Mice, Med Associates 
Inc.). The animal room had a 12 hour light/dark cycle and had an average temperature of 29.1 
± 1.7 °C (thermoneutrality) and a humidity of 40% throughout the experiment. The mice were 
fed ad libitum three times a week and received a clean water bottle with fresh water every week.  
 
2.1.5 Measurements  
Once a week the mice were weighed on a Mettler Toledo (PG42002-S/PH) weight. The mice 
were scanned with magnetic resonance imaging (MRI), using a Bruker Minispec LF50mq 7.5 
apparatus at baseline, after 5 weeks on HF/HS diet and after 5 and 7 weeks on experimental 
diets. The scanner contains a magnetic field that distinguish between fat mass, lean mass and 
free water. Every Monday, Wednesday and Friday, feed and feed remnants were weighed to 
calculate feed intake. The wooden bedding was shifted two times throughout the experiment to 
gather and weigh spilled feed. Wireless running wheels (ENV – 044, Low Profile Wireless 
Running Wheel for Mice, Med Associates Inc.) were used to obtain information about the 
mice’s physical activity.  
 
2.1.6 Feces collection 
After 4 weeks of experimental feeding, feces were collected to measure fat and nitrogen 
digestibility. The mice were transferred to a clean cage with paper sheets in the bottom, and 
after one week, feces were collected and further analyzed for fat and nitrogen content. Feed 
HF/HS 
Salmon + 
Entrecôte  
Sed 
HF/HS  
Salmon + 
entrecôte 
Ex 
LF  
Salmon  
Sed 
LF  
Salmon     
Ex 
LF 
Entrecôte 
Sed 
LF 
Entrecôte  
Ex 
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intake and fat content were noted and subsequently, apparent fat digestibility (AFD) and 
apparent nitrogen digestibility was calculated by using the following formula:  
 
𝐴𝐹𝐷 =
amount of fat eaten − amount of fat excreted 
amount of fat eaten 
 𝑥 100%  
 
2.1.7 Intraperitoneal glucose tolerance test  
To evaluate glucose tolerance, an IPGTT was performed. Prior to testing, the mice were moved 
to clean cages for 5 hours to fast. Glucose (3 mg/g lean mass) was injected with a needle into 
the stomach. A small incision was made in the lateral tail vein to measure blood glucose and 
collect blood for further GSIS analysis. The blood glucose level was measured with a 
glucometer (Countour, Bayer) before glucose was injected (T0) and after 5, 15, 30, 60 and 120 
minutes. Blood was collected at baseline and after 5, 15, 30 and 60 minutes. 20 µl of blood was 
collected into a minivette coated with EDTA and transferred into a clean Eppendorf tube. The 
blood samples were centrifuged at 1000G for 8 minutes. Plasma (10 µl) was collected and 
subsequently stored at -80 °C for further analyses described in section 2.2. At the end of the 
test, the mice’s tail were sterilized with 70% ethanol (EtOH) to prevent infection.  
 
2.1.8 Insulin tolerance test  
An ITT was performed to evaluate insulin response. The mice were placed in clean cages prior 
to the test and a prepared insulin solution (1.00 U/ kg lean mass) was injected into the 
intraperitoneal space with a needle. A small incision was made in the lateral tail vein to collect 
blood for measuring blood glucose at T0, 15 min, 30 min, 45 min and 60 min. Blood glucose 
was measured with an automatic glucometer (Contour, Bayer).  To prevent infection, the mice’s 
tail were sterilized with 70% EtOH after finishing the test. 
 
2.1.9 Termination 
Prior to termination, all mice were in a randomly fed state. The mice were anesthetized with 
isofluran (Isoba-vet, Schering Plough, Denmark) by putting them in a Univentor 400 Anesthesia 
Unit Apparatus (Univentor Limited, Sweden). Euthanasia was performed by cardiac puncture 
and by using a syringe, blood samples from the heart were transferred to a tube containing an 
EDTA anticoagulant. To separate plasma from red blood cells, the blood samples were 
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immediately centrifuged at 2500 x g at 4 °C for five minutes. The samples were stored at - 80 
°C foregoing analysis.  
 
2.1.10 Tissue and organ harvesting  
Three adipose tissues were dissected during termination: epididymal WAT (eWAT), inguinal 
WAT (iWAT) and intrascapular BAT (iBAT). Additionally, liver, pancreas and two muscles 
were excised: m. tibialis anterior and m. gastrocnemius. Furthermore, feces from colon and 
cecum was collected. The tissue and organ samples were weighed and divided into 
bags/cassettes. Samples for quantitative real- time polymerase chain reaction (qPCR) were 
snap-frozen  in liquid nitrogen and stored at -80 °C. Samples for histology were fixed in 4% 
formaldehyde. 
 
2.2 ELISA Insulin Kit   
To quantitatively determine insulin in plasma and evaluate GSIS, the insulin (Mouse) ELISA 
kit (DRG Instruments, GmbH, Germany) was applied and method was performed according to 
manufacturer’s protocol. Reagents and equipment used are presented in Table A.16 (Appendix 
VIII). 
 
The ELISA kit and samples were thawed before starting the procedure. 10 µl of each calibrator 
and sample was transferred into a 96 well microplate. Enzyme Conjugate 1X solution was 
prepared by mixing Enzyme Conjugate 11X with Enzyme Conjugate buffer. The Enzyme 
Conjugate 1X solution (100 µl) was added to each well before it was incubated on a plate shaker 
(700-900 rpm) for two hours at room temperature. During incubation, insulin reacts with 
peroxidase-conjugated anti-insulin antibodies and anti-insulin antibodies bound to the 
microplate wells. To remove unbound enzyme labeled antibody, the wells were washed six 
times with 700 µl wash buffer 1X solution using an automatic plate washer (1296-026 Delfia 
Platewash). Furthermore, 200 µl substrate Tetramethylbenzidine (TMB) was added to each 
well. The bound conjugate reacts with TMB and is detected by conversion of the uncolored 
TMB to a colored product. To stop the reaction, 50 µl of Stop Solution was transferred into 
each well. Optical density was read at 450 nm and 660 nm with a spectophometric plate reader 
(2030 Multilabel Reader. VIKTOR X5) and results were calculated.  
 
17 
 
2.3 Histology 
2.3.1 Fixation with formaldehyde and phosphate buffer  
After dissection, small sections of adipose tissue (eWAT, iWAT, iBAT), liver, pancreas and m. 
soleus was fixated in 4% paraformaldehyde in 0.1 M phosphate buffer (PB). The tissue was 
stored in fixative overnight and transferred to PB the morning after. As the tissue was stored 
for one week, a few drops of paraformaldehyde were added to the PB in order to prevent 
bacterial growth and to preserve the tissue.  
 
2.3.2 Dehydration with ethanol and xylene  
To remove fixation solutes and water from the tissue sections, PB was replaced with gradually 
increasing concentrations of EtOH, as presented in Table A.8 (Appendix IV). When the tissue 
was completely dehydrated in 100% EtOH, alcohol was substituted with xylene. Xylene was 
used because it is soluble in both alcohol and paraffin.  
 
2.3.3 Paraffin infiltration and embedding  
Paraffin was heated to 60 °C. Samples were placed in liquid paraffin (HI 1210, Leica) and 
stored overnight. To remove all remnants of xylene, paraffin was replaced twice the following 
day. Tissues were embedded in paraffin using an EC 350 Paraffin embedding center (Microtom 
International GmbH, Germany). Furthermore, tissue was placed in the center of a suitable metal 
mold where the bottom was covered with paraffin. The bed of the cassette was placed over the 
mold and filled completely with paraffin. It was kept on a cold board until it was completely 
stiffen, and the mold was removed.   
 
2.3.4 Sectioning and staining 
The samples were sent to Molecular Imaging Center at Haukeland University Hospital where 
professional technicians performed sectioning of the embedded tissue. The thickness of each 
slide was five μm. 
Prior to staining, rehydration of the tissue was necessary. The time schedule in Table A.9 
(Appendix IV), illustrates each step in the rehydration, staining and dehydration process. 
Hematoxylin was used to stain the nucleus and eosin was used to stain the cytoplasm. After 
staining, the slides were mounted with a xylene- based glue (DPX Mountant for histology, 
Sigma) and cover glass before drying in the ventilation chamber overnight.    
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2.3.5 Immunohistochemistry 
Immunohistochemestry was performed to evaluate the differences of UCP1 expression in 
iBAT. As a positive control, iBAT from cold exposed mice in an earlier study conducted on 
NIFES was included in the procedure.  
Table 2.1: Reagents and time schedule for each step in the immunohistochemistry process.   
Reagent  Time  
Citrate buffer (95°C)  2 x 15 min 
Cool down 20 min 
ddH2O 10 min  
3% H2O2 in methanol 10 min 
ddH2O 10 min  
PBS + 0,1% Tween  20 min  
PBS buffer 15 min  
Serum incubation  30 min  
Incubation with primary antibody  Overnight  
PBS buffer 60 min  
Incubation with secondary antibody 60 min  
PBS buffer 30 min  
ABC 60 min 
PBS buffer 30 min  
DAB 5 min  
Wash with H2O 2 min  
Hematoxylin  1 min  
Wash with H2O 2 min  
 
To make the tissue more reactive, rehydration was necessary. Time schedule and reagents used 
in the rehydration process are listed in Table A.10 (Appendix V), and contents of the different 
reagents and prepared solutions used are listed in Table A.12 (Appendix V). Time schedule and 
solutions used in the immunohistochemistry process are listed in Table 2.1. Phosphate buffer 
solution (PBS) was applied for “washing” the slides between each treatment. Citrate buffer was 
used for making the epitopes more available and 3% H2O2 in methanol was applied to prevent 
endogenous peroxidase activity. Incubation with goat serum was necessary to reduce non- 
specific background staining. The tissue sections were covered with antibodies, which are 
linked to a marker system so that the reaction between antibody and antigen could be visible in 
an electron microscope. Avidin – Biotin – peroxidase-complex (ABC) was added to amplify 
the signal, where peroxidase is bound to the secondary antibody to evoke color in the tissue if 
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the sample is positive. The final step before staining was completed by dripping 
Diaminobenzidin tetrahydroklorid (DAB) onto the incision where ABC oxidizes DAB, causing 
it to precipitate and the location of the antigen in the tissue is colored. Lastly, the tissue was 
dehydrated according to Table A.11 (Appendix V) and a cover glass was mounted on the slides 
using the cover glue Histomount (Invitrogen 008030).  
 
2.3.6 Microscopy  
The cell morphology of liver and adipose tissue (eWAT, iWAT, iBAT) was examined by using 
an Olympus BX 51 binocular microscope. An Olympus DP50 3.0 camera was used for 
photographing a representative field from each section. UCP1 expression was quantified by 
using Image J.    
 
2.4 Real time qPCR 
To identify relative gene expression of certain genes in the liver, ribonucleic acid (RNA) from 
liver was isolated and several steps were performed before real-time qPCR was conducted. 
2.4.1 Homogenization and RNA purification 
A small piece of tissue (50 mg) was weighed and transferred to an RNase free-tube together 
with 1 ml Trizol (Invitrogen, UK) and 4 zinconium beads. The samples were homogenized 
using a Precellys 24 lysis & homogenization instrument (Bertin Technologies, France) at 6000 
rpm for 3 x 10 seconds. Incubation time was 5 minutes before 200 µl chloroform (VWR, 
Norway) was added to the tubes and shaken vigorously for 20 seconds. Furthermore, samples 
were incubated for 3 minutes at room temperature and centrifuged (4 °C, 15 min, 1200 rpm). 
The aqueous phase was transferred to a new tube where 500 µl isopropanol (Arcus Kjemi, 
Norway) was added. Two incubation steps followed, 10 minutes at room temperature and 45 
minutes at 4°C. A new centrifugation was conducted (4°C, 30 min, 1200 rpm), and a pellet was 
formed. Supernatant was removed from the pellet by using a vacuum suction instrument (IBS 
Integra Bioscienses, Vacuboy Swizerland) and 1 ml cold 75% EtOH was added. Vortex was 
conducted before centrifugation (4°C, 15 min, 1200 rpm). Supernatant was once more removed 
using a vacuum instrument and 50-100 µl ddH2O was added to dissolve the pellet. Finally, 
RNA concentration was measured with Nanodrop ND-1000 spectrophotometer (Saveen 
Werner, Sweden) by placing 1.8 µl of sample directly on the measurement pedestal. 
Additionally, the ND-1000 calculated absorbance and the A260/A280 ratio and A260/A230 
ratio, which give an indication of quality and quantity of the RNA samples.    
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2.4.2 RNA Precipitation 
Measurement done on the Nanodrop ND-1000 spectrophotometer did not give high enough 
260/230 ratios, and RNA Precipitation was needed. This was done by adding 0.1 times the 
volume of Sodium Acetat (3 M, Sigma) and 2.5 times the volume of 96% EtOH to each sample 
before it was frozen at -80 °C overnight. The following day, samples were centrifuged (4°C, 30 
min, 1200 rpm). Supernatant was removed and 1 ml of 75% EtOH was added. Furthermore, 
samples were centrifuged before supernatant was removed again. To make the sample as clean 
as possible, it was important to remove every drop of EtOH without losing the pellet. Lastly, 
water was added to the samples and RNA concentration, absorbance and ratio was measured. 
 
2.4.3 Measure of RNA integrity, BioAnalyzer 
The quality of the purified RNA samples was analyzed by using BioAnalyzer RNA 6000 and 
an RNA LabChip kit (Agilent Technologies). The chip constitutes 16 wells, where 12 are filled 
with RNA samples, three are filled with gel dye mixture and one well is filled with a molecular 
size ladder (Ambion, USA). RNA is separated due to molecular size in a micro channel system 
where RNA migration is detected based on the ratio between size and charge of the RNA 
molecules. Software calculates RNA Integrity Number as well as an image and 
electropherogram occur, which provides information about the integrity of the RNA samples.    
A random selection of 12 samples were used to determine the quality. Before start, reagents 
were incubated at room temperature for 30 minutes and the heating block was set to 70 °C. To 
make the Gel-dye mix, RNA Nano dye (0.5 µl) was added to 32.5 µl filtrated gel matrix and 
centrifuged (4 °C, 10 min, 13000 rpm). Gel- dye mix (9 µl ) was added in the G- marked well 
in the RNA 600 Nano chip. The chip priming station was closed and the plunger was held down. 
Following 30 seconds of incubation, the piston was released by a “clip mechanism”. After 5 
seconds, the piston was dragged carefully back to 1 ml position. Gel-dye mix was supplied to 
the two other g-marked wells and 5 µl of RNA – 6000 marker was added to each well except 
wells with added gel. Ladder was applied in the well marked a ladder and furthermore, 1 µl of 
RNA sample was pipetted into each of the remaining wells. Finally, the chip was placed in the 
Agilent 2100 Bioanalyzer (Agilent Thechnologies, USA). 
 
2.4.4 Reverse transcription reaction 
Before running qPCR, a reverse transcription (RT) reaction from RNA to complementary 
Deoxyribonucleic acid (cDNA) was necessary. All reagents and samples were kept on ice 
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throughout the procedure. RNA – samples (n = 60) were thawed on ice and diluted into a 
concentration equal to 50 ng/µl ± 5%. The concentration of the prepared samples were further 
measured on the Nanodrop ND-1000 spectrophotometer. A standard curve was made by 
pooling RNA, where 2 µl of a random selection of 30 samples were added into a new tube. The 
pooled RNA- samples were used to make a solution with the concentration 100 ng/µl. 
Furthermore, a double dilution of the 100 ng/µl was prepared in five new tubes (Figure 2.4) and 
concentration was measured.  
  
 
 
 
Figure 2.4: Dilution of RNA – samples for standard curve.  
 
The RT reaction mix was prepared as described in Table A.13 (Appendix VI). For quality 
assessment, two negative controls were included, a non- amplification control (without 
multiscribe enzyme) and a non-template control (lacking RNA template). The pipetting was 
conducted in a 96-well RT-plate, where 40 µl of the reaction mix and 10 µl of each RNA – 
sample was added into each well. A 96-well full plate cover was affixed on top of the wells and 
it was centrifuged (50 x g, 1 min). Furthermore, the plate went through a thermal cycling RT 
reaction using a Gene AMP PCR System 9700 PCR machine (Applied biosystems), which 
program is presented in Table A.14 (Appendix VI). Finally, the 96-well plate was covered with 
a tape pad and stored at -20 °C. 
   
2.4.5 Quantitative real-time polymerase chain reaction 
To quantify gene expression in the liver, qPCR was conducted. Sequence-specific primers are 
used to determine the relative number of copies of a particular DNA Sequence. qPCR amplifies 
small DNA sequences encoding a small section of the gene one wishes to analyze. The 
amplification of DNA is exponential and is accomplished using fluorescent DNA – binding 
dye. The qPCR instrument measures the fluorescence and increased fluorescent signal is 
directly proportional to expression of the gene.     
The volume of the cDNA plate was doubled by adding 50 µl ddH2O. Furthermore, the cDNA 
plate was centrifuged (1000 x g, 1 min) and vortexed (1300 rpm, 3 min) prior to the real time 
PCR reaction. Real Time PCR Mix was made according to Table 2.2. 
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Table 2.2: Reagents and volume used for the SYBR Green reaction mix. 
Reagent Volume (µl)  Vendor 
ddH2O 
Primer I 
Primer II 
SYBR Green PCR Master Mix 
335.5 
5.75 
5.75 
575 
MiliQ BioCel, USA 
Invitrogen, UK 
Invitrogen, UK 
Roche - Norge 
 
The prepared qPCR reaction mix (112 µl) was added to an eight -strips tube so that the pipetting 
could be carried out by a robot (Biome 3000 Laboratory Automation Workstation, Beck 
Coulter, USA). Reaction mix (8 µl) and cDNA sample (2 µl) was added to each well in a 384 
well plate. Furthermore, the plate was covered with an optical adhesive cover and centrifuged 
for 2 minutes at 1500 x g. Finally, the real-time PCR reaction was performed using the Light 
Cycler 480 machine. 
 
2.5 Statistical analyses  
2.5.1 Microsoft Exel 2013 
Processing of raw data and calculation of standard deviation as well as Standard Error of the 
Mean (SEM) was made in Microsoft Exel.   
 
2.5.2 Graph pad prism 6 and Statistica 12 
Graph pad prism 6 was used to identify outliers by applying Grubb’s test and normal 
distribution was tested in Statistica 12. Data in Figure 1 and 2 were tested by a parametric 
unpaired t- test in Graph pad and Repeated Measurements (RM) one-way analysis of variance 
(ANOVA) with unequal N HSD post hoc test in Statistica 12. The results from feeding 
experiment 1 are compared with a previous experiment done on NIFES where the group size 
varies from our experiment. On the remaining data, a one-way ANOVA with Fisher LSD 
multiple comparison in Graph pad was used to analyze differences between the six groups. To 
analyze weight development, accumulated feed intake as well as blood glucose levels during 
IPGTT and ITT, a RM ANOVA test with LSD multiple comparison post hoc test was applied 
in Statistica. Data were considered significant when p < 0.05. Statistical significance between 
the experimental groups are marked with different letters. Additionally, a two- ways ANOVA 
was applied only on data from the LF fed groups, to compare the effect of protein source with 
exercise. The results of these data are illustrated in a textbox in the figures where p – values up 
to 0.1 is mentioned. P value < 0.05 is considered statistic significant and marked *.  
23 
 
3.0 RESULTS 
To induce obesity, 70 mice were fed a HF/HS diet as presented in Table A.2 (Appendix I) for 
seven weeks. In order to evaluate how replacement of casein with salmon and entrecôte in a 
HF/HS diet affected diet-induced obesity (DIO), weight development, feed intake and results 
from IPGTT and ITT was compared with a previous study done at NIFES, where casein was 
the only protein source (n = 8).  
 
3.1 Casein, salmon and entrecôte in a HF/HS diet promoted obesity    
Despite similar energy intake, replacement of 2/3 of casein with salmon and entrecôte in a 
HF/HS diet caused a sharp increase in BW and fat mass. As illustrated in Figure 3.1 A-C, a 
HF/HS diet with casein, salmon and entrecôte as protein source induced obesity after six weeks 
of feeding. An MRI scan of the mice were performed prior to the feeding experiment and after 
five weeks to see if the weight gain was due to an increase in fat mass or lean mass. Figure 3.1 
A illustrates that the weight gain in the mice fed a HF/HS (Casein, Salmon and Entrecôte) diet 
is attributable to an increase in fat mass. The BW development during six weeks of feeding was 
significantly higher in mice fed casein, entrecôte and salmon compared to the mice fed solely 
casein. As a result, BW gain after six weeks of feeding was significantly higher in the mice fed 
HF/HS (Casein, Salmon and Entrecôte) compared to the mice fed HF/HS (Casein). 
Nevertheless, energy intake was virtually the same in the group fed casein, salmon and entrecôte 
and the group fed only casein (Figure 3.1 D-E). Furthermore, as illustrated in Figure 3.1 F, feed 
efficiency was significantly higher in mice fed HF/HS (Casein, Salmon and Entrecôte) 
compared to mice fed HF/HS (Casein), which underscores the fact that the mice who consumed 
casein and animal protein gained more weight than the mice fed solely casein.  
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Body weight development, energy intake and feed efficiency 
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Figure 3.1: Replacing casein with animal protein caused a sharp increase in body weight and fat mass despite 
similar energy intake. A: Body composition before and after five weeks on a HF/HS diet with casein, entrecôte 
and salmon as protein source. B: Body weight development during six weeks of feeding on a HF/HS diet. C: Body 
weight gain. D: Total energy intake during three weeks of feeding. E: Accumulated energy intake during week 1, 
2 and 5. F: Calculated feed efficiency. Group variations in body weight gain, total energy intake and feed efficiency 
were analyzed using a parametric unpaired t- test. Weight development and accumulated energy intake were 
analyzed by using RM ANOVA with unequal N HSD post hoc test. Different letters denote statistical significance 
(p < 0.05) between the mean in each group. The results are presented as mean ± SEM.  
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3.2 Glucose tolerance and insulin sensitivity was impaired by HF/HS feeding 
with casein, salmon and entrecôte  
To evaluate the impact of protein source on glucose tolerance and insulin sensitivity, an IPGTT 
and ITT were performed after six weeks of experimental feeding. Figure 3.2 illustrates glucose 
levels prior to and throughout the tests and calculated Area Under the Curve (AUC).  
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Figure 3.2: Intraperitoneal glucose tolerance test performed on fasting mice (6 h) and Insulin Tolerance Test 
performed on randomly fed mice after six weeks of feeding diets. A: Fasting blood glucose. B: Blood glucose 
levels during IPGTT. C: Calculated area under curve during IPGTT. D: Fed blood glucose. E: Blood glucose 
levels during ITT. F: Calculated area under curve during ITT. Group variations in blood glucose and AUC were 
analyzed using a parametric unpaired t- test. Blood glucose levels measured during IPGTT and ITT were analyzed 
by using Repeated Measurement ANOVA test with unequal N HSD post-hoc test. Different letters denote 
statistical significance (p < 0.05) between the mean of the groups. The results are presented as mean ± SEM.  
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The results from IPGTT indicate that there is an association between high BW, high fasting 
blood glucose and lowered glucose tolerance. Measuring blood glucose after six hours of fasting 
showed that mice fed casein, salmon and entrecôte in a HF/HS diet had elevated levels of blood 
glucose compared to mice fed solely casein on the same diet (Figure 3.2 A). Additionally, 
Figure 3.2 B illustrates that mice fed casein, salmon and entrecôte had an impaired glucose 
tolerance compared to mice fed casein alone. However, compared to a LF reference diet (RD), 
the mice fed casein also had an impaired glucose tolerance. To evaluate glucose clearance 
between mice fed casein, salmon and entrecôte with mice fed merely casein, AUC was 
calculated.  A parametric unpaired t – test of glucose AUC showed that the glucose clearance 
was significantly better in mice fed casein compared to mice fed casein, salmon and entrecote 
(Figure 3.2 C).  
 
Results from ITT also demonstrated an association between high BW and impaired insulin 
sensitivity (Figure 3.2 D-F). The differences in blood glucose prior to test start was statistically 
significant between mice fed casein, salmon and entrecôte and mice fed only casein, where 
mice fed casein, salmon and entrecôte had higher fed blood glucose levels than mice fed casein 
(Figure 3.2 D). Figure 3.2 E demonstrates that mice fed casein, salmon and entrecôte had 
impaired insulin sensitivity compared to mice fed casein and mice fed a LF diet. There is a 
minimal response in blood glucose in the mice fed casein, salmon and entrecôte, which mean 
they cannot be defined completely insulin resistant; however, the insulin sensitivity is clearly 
impaired. The calculated AUC was significantly lower in the casein- fed mice compared to the 
casein, salmon and entrecôte – fed mice, which reinforces the fact that the latter group is less 
insulin sensitive.  
 
3.3 Body weight change due to exercise was greater in mice fed LF diets than 
in mice fed HF/HS diets.   
After being assigned a HF/HS diets for seven weeks, 60 of the most average mice were divided 
into six groups based on BW, fat mass and lean mass. To investigate if DIO, impaired glucose 
tolerance and insulin sensitivity was reversible by changing diet, two of the groups remained 
on a HF/HS diet (Table A.2, Appendix I) as a control, and the four remaining groups switched 
to a LF diet (Table A.2, Appendix I). To evaluate the effect of different protein sources, two 
groups were fed entrecôte as main protein source and two groups were fed salmon. Three of the 
groups (defined as Ex) received running wheels to evaluate the impact of voluntarily exercise. 
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BW, physical activity and feed intake were measured throughout the period. In the following 
figures, the mice fed LF diets are termed by the protein source received.  
 
Body weight development, body weight change and exercise 
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Figure 3.3: The effect of diet and/or exercise on  body weight development (A), body weight change after seven 
weeks (B) and elapsed mean run distance per week (C). Weight development was analyzed by RM ANOVA. 
Group variations of body weight change and physical activity were analyzed using a one-way ANOVA test with 
multiple comparison (Uncorrected Fisher’s LCD) of the mean of each experimental group. Different letters denote 
statistical significance (p < 0.05) between the mean of the groups. The results are presented as mean ± SEM. 
Additionally, a two way ANOVA was applied to determine whether protein source (P) or exercise (Ex) had an 
impact on differences in body weight change or exercise, and statistical significance is marked *. 
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As presented in Figure 3.3A, different diets stimulated weight gain at different rates. However, 
there was no significant difference between mice fed salmon or entrecôte in the LF diets. The 
effect of exercise on BW development during seven weeks was not statistically significant in 
either group. One way ANOVA analyzes of BW change data (Figure 3.3 B) did not show any 
difference between the Sed and Ex group in the mice fed HF/HS; however, BW change was 
affected by exercise in the mice fed LF entrecôte. In the LF salmon-fed mice the difference 
between the Ex and Sed group was not statistically significant, but the p – value was 0.0520. 
Nonetheless, results from two ways ANOVA comparing exercise with protein source in the LF 
groups, demonstrated that exercise made a significant difference regarding weight loss in both 
entrecôte and salmon – fed mice. Figure 3.3 C illustrates the level of mean physical activity in 
the different groups that received running wheels. The mice fed LF salmon and LF entrecôte 
run significantly longer than the mice fed HF/HS diet. 
 
3.3.1 Fat digestibility was lower in mice fed entrecôte than mice fed salmon 
To evaluate if changes in BW was due to differences in energy intake, feed intake was 
monitored throughout the experimental period. Total BW change and total energy intake were 
used to determine feed efficiency (g/Mcal). Furthermore, to evaluate if the changes in BW and 
feed efficiency was due to differences in fat or nitrogen excretion, feces were collected and 
their fat and nitrogen content analyzed.   
 
The mice fed HF/HS had the same accumulated energy intake, regardless of exercise (Figure 
3.4 A). The mice fed HF/HS had a higher accumulated energy intake than the LF groups, with 
the exception of the sedentary mice fed LF salmon, they had similar accumulated energy intake 
as exercised mice fed HF/HS. Nevertheless, sedentary mice fed LF salmon did not differ 
significantly from the other LF groups when analyzing accumulated energy intake. Figure 3.4 
B illustrates that mean energy intake per week is significantly higher in both of the HF/HS fed 
groups compared to the LF-fed groups. Furthermore, neither training nor protein source seems 
to determine energy intake. To evaluate the obesogenic or slimming effect of the different diets, 
feed efficiency was calculated. As expected, feed efficiency was much higher in the HF/HS fed 
mice than mice fed LF diets. There was however no significantly difference between salmon 
and entrecôte – fed mice. Both of the LF groups assigned to exercise had lower feed efficiency 
than the sedentary groups receiving LF diets.  
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Energy intake, feed efficiency and apparent fat and nitrogen digestibility 
Figure 3.4: Energy intake (A-B), feed efficiency (C) and apparent fat (D) and nitrogen (E) digestibility in mice 
fed a HF/HS (Casein, salmon and entrecôte) and LF diets with salmon or entrecôte as protein source. Accumulated 
feed intake was analyzed by RM ANOVA. Differences in weekly feed intake, feed efficiency and apparent fat and 
nitrogen digestibility were analyzed using a one- way ANOVA test with multiple comparison (Uncorrected 
Fisher’s LCD) of the mean of each experimental group. Different letters denote statistical significance (p < 0.05) 
between the mean of each group. The results are presented as mean ± SEM. A two way ANOVA was used to 
determine whether protein source or exercise had an impact on differences in feed intake, feed efficiency or 
digestibility and statistical significance is marked *.  
 
Interestingly, results from one way ANOVA showed that fat digestibility was significantly 
lower in the mice fed LF entrecôte compared to the mice fed LF salmon and the mice fed 
HF/HS. Additionally, a two ways ANOVA of the LF – groups reinforced that the protein source 
(entrecôte) was a determining factor regarding fat digestibility. As opposed to protein source, 
Ex did not seem to influence fat digestibility. Figure 3.4 E illustrates that the apparent Nitrogen 
digestibility was significantly lower in the mice fed LF than in the mice fed HF/HS.     
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3.4 Exercise combined with low fat diet was beneficial for changes in body 
composition  
To determine whether BW change was attributable to changes in fat mass or lean mass, the 
mice were MRI scanned prior to feeding experiment 2 and after five and seven weeks. The 
results from the MRI scan in week 5 as well as the changes in fat- and lean mass from week 0-
5 are presented in Figure 3.5. During termination, visceral (eWAT) and subcutaneous (iWAT) 
adipose tissue depots was excised and weighed to evaluate whether differences in fat mass could 
be attributed to mass – differences between the various adipose tissue depots. Additionally, to 
evaluate if the changes in lean mass could be due to changes in muscle weight, musculus tibialis 
anterior and musculus gastrocnemius were excised and weighed, and the results are presented 
in Figure A.7 (Appendix VII). 
 
As illustrated in Figure 3.5 A, after five weeks fed experimental diets, fat mass was significantly 
higher in the mice fed HF/HS, while exercise did not seem to influence fat mass in this group. 
The same trend was observed in the mice fed LF salmon; however, the p-value between the Sed 
and Ex group in the mice fed LF salmon was 0.062 and 0.065 in the mice fed HF/HS. In the 
mice fed LF entrecôte, the difference in fat mass between Sed and Ex group was statistically 
significant. Evaluating the changes in fat mass from week 0 – 5, both of the LF groups assigned 
to exercise had a significantly higher fat – mass reduction than their respective sedentary group. 
Nevertheless, in the mice fed HF/HS diets, there was no statistical difference between Sed and 
Ex group, indicating that exercise had no impact on fat mass reduction in mice fed HF/HS. 
Additional results from the MRI scan showed that after 5 weeks, mice assigned to exercise and 
fed LF entrecôte, was the only group that had statistically higher lean mass than the mice fed 
HF/HS. Nonetheless, looking at the change in lean mass, both groups fed LF diets, regardless 
of exercise had a higher lean mass increase than the mice fed HF/HS; furthermore, the exercised 
mice fed LF entrecôte had significantly higher lean mass than the sedentary mice fed LF 
entrecôte. Results from two ways ANOVA demonstrates that the protein source is not crucial 
for changes in lean mass; however, the p-value for exercise is 0.053, indicating that exercise 
may increase lean mass in mice fed LF diets.  
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MRI scan of fat mass and lean mass and adipose tissue depots 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Body composition and body composition change in the different groups (n=9-10). A: Fat mass after 5 
weeks on experimental diets. B: Fat mass change during 5 weeks. C: Lean mass after 5 weeks on experimental 
diets. D: Lean mass increase after 5 weeks. E: Masses of eWAT at termination (Week 7) F: Masses of iWAT at 
termination. Group variations in fat mass, lean mass and adipose tissue mass were analyzed using a one-way 
ANOVA with multiple comparison (Uncorrected Fisher’s LCD) of the mean of each experimental group. Different 
letters denote statistical significance (p < 0.05) between the mean of the groups. The results are presented as mean 
± SEM. A two way ANOVA was used to determine whether protein source or exercise had an impact on 
differences in fat- or lean mass, eWAT and iWAT in the mice fed a LF diet and statistical significance is marked 
*. 
 
Figure 3.5 E indicates that a LF diet alone does not affect the weight of eWAT; however, 
combining exercise with a LF diet reduced the weight of eWAT in mice fed salmon and 
entrecôte. Figure 3.5 F demonstrates that a LF diet alone had an impact on iWAT weight, as 
the mice fed LF diets had significantly lower weight of iWAT than the mice fed HF/HS. In the 
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mice fed HF/HS, exercise did not seem to be of importance, and neither in the LF salmon group 
when evaluating results from one way ANOVA; however, in the mice fed LF entrecôte, exercise 
made a difference, as iWAT weight was significantly lower in the Ex group than the Sed group. 
Furthermore, a two-way analyzes on eWAT weight in the LF groups demonstrated that exercise 
influenced the weight of iWAT.   
 
3.4.1 Adipocyte size in white adipose tissue 
The adipocyte size in white adipose depot (eWAT and iWAT) was examined by staining and 
microscopy of a representative part.  
 
                                                    Adipocyte size in eWAT 
                                           Sed                                                      Ex 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Adipocyte micrographs in epididymal adipose tissue in mice fed HF/HS, LF salmon 
and LF entrecôte, with and without exercise. (Micrographs are magnified x 20) 
HF/HS 
LF Salmon 
LF Entrecôte 
100 µm 
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The micrographs of eWAT (Figure 3.6) supports that neither diet nor protein source seems to 
influence adipocyte size in eWAT. This is in accordance with Figure 3.5 E, which demonstrate 
no difference in eWAT weight between sedentary mice fed HF/HS and LF. Figure 3.5 E further 
illustrates a difference between Ex and Sed group mice fed LF diets; however, the micrographs 
from Figure 3.6 cannot confirm whether this difference is attributable to differences in 
adipocyte size. 
 
Adipocyte size in iWAT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Adipocyte micrographs in subcutaneous adipose tissue (iWAT) in mice fed 
HF/HS, LF salmon and LF entrecôte, with and without exercise (Micrographs are magnified 
x 20). 
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The micrographs in Figure 3.7 indicate that exercise makes the size of the lipid droplets in 
iWAT smaller in mice fed HF/HS. The differences between Sed and Ex are not that obvious in 
the LF groups; however, the lipid droplets in LF salmon Ex group seems smaller than in the 
Sed group. In any case, the lipid droplets in the LF groups looks smaller than in the HF/HS 
group and are consistent with Figure 3.5 F, which indicates that a LF diet reduce adipocyte size 
in iWAT.  
 
3.5 Brown adipose tissue  
To evaluate if diet, exercise or protein source could affect the BAT, iBAT was excised and 
weighed during termination. The adipocyte size in iBAT was examined by staining and 
microscopy a representative part.  
 
Figure 3.8 A illustrates that the weight of iBAT is not influenced by exercise in the mice fed 
HF/HS. All LF groups except LF salmon Sed had significantly lower iBAT weight than both 
HF/HS groups. Although analyses with one- way ANOVA did not demonstrate significant 
differences between Ex and Sed group in the mice fed LF diet, analyses with two- way ANOVA 
indicates that exercise determines the weight of iBAT in the mice fed LF diets. The micrographs 
of iBAT illustrated in Figure 3.8 B suggest that the differences in iBAT weight between the 
mice fed HF/HS and the mice fed LF is attributable to reduced lipid accumulation in the mice 
fed LF. However, whether the adipocytes becomes smaller with exercise in either group, cannot 
be said by merely considering the micrographs.  
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Weight and adipocyte size of iBAT 
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Figure 3.8: Masses of iBAT (A) and adipocyte micrographs (B) in mice fed HF/HS, LF 
salmon and LF entrecôte, with and without exercise. Group variations in iBAT were 
analyzed using a one-way ANOVA test with multiple comparison (Uncorrected Fisher’s 
LCD) of the mean of each experimental group. Different letters denote statistical 
significance (p < 0.05) between the mean of each group. The results are presented as mean 
± SEM. A two ways ANOVA was used to determine whether protein source or exercise 
had an impact on differences in iBAT weight and statistical significance is marked *. 
(Micrographs are magnified x 20) 
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3.5.1 UCP1 expression in iBAT 
To investigate if diet, exercise or protein source influenced energy expenditure trough the 
expression of UCP1, immunohistochemistry was performed and additional micrographs were 
taken to quantify UCP1 in iBAT.  
 
Evaluating the micrographs in Figure 3.9 A confirms that diet have an impact on the size of the 
lipid droplets in iBAT. Furthermore, Figure 3.9 B and micrographs indicate that the expression 
of UCP1 is slightly elevated in mice fed LF than in mice fed HF/HS diet. In addition, by looking 
carefully at the micrographs and evaluating Figure 3.9 B, exercise may possibly have an effect 
on the size of the lipid droplets as well as the expression of UCP1, at least in the mice fed LF 
salmon. Nevertheless, the expression of UCP1 is impaired in the mice in our experiment, 
regardless of diet and exercise in contrast to the expression of UCP1 in mice fed high fat – high 
protein (HF/HP) diets in an earlier study conducted by our research group. By comparing Figure 
3.9 A with Figure A.2 (Appendix V), the reduced expression of UCP1 in the mice from our 
experiment becomes apparent. Figure A.2 illustrates appearance of iBAT in mice fed a HF/HP 
diet, in addition to after cold exposure. The micrographs in Figure A.2 demonstrates a higher 
number of multilocular cells, which is a characteristic of BAT. Evaluating Figure 3.9 A, it 
seems that the low expression of UCP1 may be due to white fat accumulation in iBAT. This 
further makes it possible to speculate on whether a LF diet or exercise permits elevation of 
UCP1 expression in iBAT after mice have been obese on a HF/HS diet with salmon and 
entrecôte as protein source.  
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                                                            Expression of UCP1 in iBAT 
               A                                 Sed                                                         Ex 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             
 
 
 
 
 
 
 
Figure 3.9: Adipocyte micrographs (A) and quantified UCP1 expression (B) in mice fed HF/HS, LF salmon 
and LF entrecôte, with and without exercise. Group variations in the expression of UCP1 in iBAT was 
analyzed using a one-way ANOVA test with multiple comparison (Uncorrected Fisher’s LCD) of the mean 
of each experimental group. Different letters denote statistical significance (p < 0.05) between the mean of 
the groups. The results are presented as mean ± SEM. (Micrographs are magnified x 20) 
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3.6 Insulin sensitivity was improved by diet and exercise, but only diet 
influenced glucose tolerance.    
To evaluate the impact of diet, exercise and protein source on glucose tolerance and insulin 
sensitivity, an IPGTT and ITT was performed after six weeks of experimental feeding. The 
results from the IPGTT are presented in Figure 3.10 and the results from ITT in Figure 3.11. 
 
Intraperitoneal Glucose Tolerance Test 
Figure 3.10: Effect of diet on glucose regulation. A: Fasting blood glucose B: Blood glucose levels during IPGTT 
performed on fasting mice (6 h) after five weeks on the experimental diets. C: Calculated area under curve during 
IPGTT D-F: GSIS at baseline and after 15 and 60 minutes during IPGTT. Group variations in fasting blood 
glucose, AUC of IPGTT and plasma insulin were analyzed using a one-way ANOVA test with multiple 
comparison (Uncorrected Fisher’s LCD) of the mean of each experimental group. Variations in blood glucose 
during IPGTT were analyzed using a Repeated Measurement one-way ANOVA with multiple comparison 
(Uncorrected Fisher’s LCD) of the mean of each experimental group. Different letters denote statistical 
significance (p < 0.05) between the mean of the groups. The results are presented as mean ± SEM.  
 
The results from IPGTT indicates that a LF diet significantly improves glucose tolerance. 
Figure 3.10 A-C illustrates that mice fed a LF diet, regardless of protein source or exercise, 
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have a significantly lower fasting blood glucose and improved glucose tolerance than mice fed 
a HF/HS diet, displayed during the IPGTT and calculation of AUC. Additionally, plasma 
insulin was analyzed at baseline, after 15 and 60 minutes. The results showed that the levels of 
insulin were significantly higher in the HF/HS fed mice and that neither exercise nor protein 
source seemed to be of importance.  
 
                                                         Insulin Tolerance Test 
Figure 3.11: Effect of diet, protein source and/or exercise on insulin sensitivity. A: Randomly fed blood glucose 
levels in the different groups (before test start). B: Delta blood glucose 15-0 min. C: Blood glucose levels during 
Insulin Tolerance test (ITT). D: Calculated area over the curve (AOC). Differences in fed blood glucose, Δ 
Blood glucose and AOC were analyzed using a one-way ANOVA test with multiple comparison (Uncorrected 
Fisher’s LCD) of the mean of each experimental group. Variations in blood glucose during ITT were analyzed 
using a repeated measurement one-way ANOVA with multiple comparison (Uncorrected Fisher’s LCD) of the 
mean of each experimental group. Different letters denote statistical significance (p < 0.05) between the mean 
of the groups. The results are presented as mean ± SEM. Additionally, a two ways ANOVA was used to 
determine whether protein source or exercise had an impact on differences in fed blood glucose, Δ Blood 
glucose and AOC in the LF groups and statistical significance is highlighted and marked with *.  
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As presented in Figure 3.11, fed blood glucose was significantly higher in the sedentary mice 
fed HF/HS than in all other groups. Furthermore, the mice fed LF entrecôte had significantly 
lower fed blood glucose than mice fed LF salmon. This is further supported by analyzing the 
data with a two ways ANOVA, which demonstrated that protein source affected fed blood 
glucose; however, exercise did not seem to be of importance. Changes in blood glucose from 0 
– 15 minutes was significantly higher in the LF groups compared to the HF/HS groups with the 
exception of the sedentary mice fed LF salmon, this group was not significantly different from 
the HF/HS Ex group; nevertheless, the p – value between the two groups was 0.052. The impact 
of exercise on changes in blood glucose did not seem to be of importance; however there was 
a trend towards reduced blood glucose observed in the exercised mice fed HF/HS (p = 0.062). 
Analyzing blood glucose levels during ITT (Figure 3.11 C) with RM ANOVA demonstrates 
that exercise improves insulin sensitivity in the mice fed HF/HS but not in the mice fed LF. 
Furthermore, the LF groups demonstrates improved insulin sensitivity compared to HF/HS 
groups, with the exception of sedentary mice fed LF salmon, which do not have a significantly 
enhanced insulin sensitivity compared to exercised mice fed HF/HS diet. 
 
In light of the finding that fed blood glucose was elevated in all groups, AOC was calculated to 
evaluate the response of insulin injection on blood glucose, independent of blood glucose levels 
at baseline. Figure 3.11 D illustrates that mice fed LF diets have an improved response to insulin 
compared with mice fed HF/HS diets. Furthermore, Figure 3.11 D demonstrates that in mice 
fed HF/HS and LF salmon, exercise seems to improve insulin response. The improvement by 
exercise was however not apparent in the mice fed LF entrecôte. Exercised mice fed LF Salmon 
had improved blood glucose lowering effect of insulin than sedentary mice fed LF diets. A two-
way ANOVA analyzes of AOC indicates that exercise improves insulin sensitivity in mice fed 
LF diets.  
 
3.7 Switching to a low fat diet reduced liver weight  
The liver was excised and weighed during termination. To evaluate whether differences in liver 
mass were due to fat accumulation or accompanied with any pathological findings, the liver 
was examined by staining and microscopy of a representative part.  
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Liver weight and micrographs 
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Figure 3.12: Liver weight (A) and liver micrographs (B) in the different groups. Group variations 
in liver mass was analyzed using a one-way ANOVA test with multiple comparison (Uncorrected 
Fisher’s LCD) of the mean of each experimental group. Different letters denote statistical 
significance (p < 0.05) between the mean of the groups. The results are presented as mean ± SEM. 
(Micrographs are magnified x 20) 
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Figure 3.12 (A) demonstrate an association between the diet and liver weight. All of the mice 
fed LF diets had significantly lower liver mass than mice fed HF/HS diets. Exercise did not 
seem to affect the liver size in neither group. The micrographs (B) illustrate that an elevated 
liver mass in mice fed HF/HS diets is most likely attributable to a higher fat accumulation, as 
the fat droplets are more evident in these groups compared to the mice fed a LF diet. Consistent 
with Figure 3.12 A, the micrographs of mice fed HF/HS does not indicate that exercise in this 
group reduces fat accumulation in the liver. Whether protein sources or exercise influence fat 
accumulation in the mice fed LF diets, cannot be detected by merely evaluating the 
micrographs.  
 
3.7.1 Expression of genes involved in fatty acid uptake, synthesis and oxidation 
To investigate the effect of a LF diet, protein source and/or exercise on variations in hepatic 
lipid accumulation, the expression of genes involved in FA uptake, synthesis and oxidation 
were measured.  
 
Figure 3.13 demonstrates that there were no differences in the expression of Acc1 in neither 
group. The expression of Fasn was significantly lower in the mice fed LF diets and in the 
HF/HS Ex group compared to the HF/HS Sed group. However, the expression of Scd1 was 
lower in the exercised mice fed LF salmon compared to both the Sed and Ex group fed LF 
entrecôte. Results from two-ways ANOVA further indicates that protein source alters the 
expression of Scd1, where the mice fed LF salmon had a lower relative expression than the 
mice fed LF entrecôte. Furthermore, expression of genes involved in FA uptake was lower in 
the LF groups compared to the mice fed HF/HS, with the exception of Adrp. Compared to 
sedentary mice fed HF/HS, the expression of Adrp was only significantly lower in the mice fed 
LF entrecôte. Analyzing the expression of Cd36 with a two ways ANOVA in the LF groups 
demonstrated that protein source influenced the relative expression of Cd36, where it was lower 
in the mice fed entrecôte.  
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Expression of genes involved in lipid synthesis and fatty acid uptake 
 
Figure 3.13: Relative expression of genes involved in lipid synthesis (A-C) and fatty acid uptake (D-F) in the 
liver. Differences in gene expression were analyzed using a one-way ANOVA test with multiple comparison 
(Uncorrected Fisher’s LCD) of the mean of each experimental group. Different letters denote statistical 
significance (p < 0.05) between the mean of the groups. The results are presented as mean ± SEM. To evaluate 
whether protein source or exercise had an impact on differences in relative gene expression, a two ways ANOVA 
was applied on the LF groups and statistical significance is marked *.   
 
 
 
0 .0
0 .5
1 .0
1 .5
2 .0
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
A c c 1
0 .0
0 .5
1 .0
1 .5
2 .0
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
A d rp
a a b
b
0 .0
0 .5
1 .0
1 .5
2 .0
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
 F a s n
a
b
          p -  v a lu e
P         0 .0 9 1
E x       0 .5 3 4
0 .0
0 .5
1 .0
1 .5
2 .0
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
F a b p 1
a
a b b
0 .0
0 .5
1 .0
1 .5
2 .0
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
a b c
b
a c
p  =  0 .0 8 2 8
p  =  0 .0 8 1 6
          p -  v a lu e
P         0 .0 2 4 *
E x       0 .0 7 9
S c d 1
a b c
a b c
0 .0
0 .5
1 .0
1 .5
2 .0
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
a
b
          p -  v a lu e
P         0 .0 4 6 *
E x       0 .2 0 8
C d  3 6
H F /H S  S e d H F /H S  E x S a lm o n  S e d S a lm o n  E x E n tre c o te  S e d E n tre c o te  E x
A
B
C
D
E
F
44 
 
Expression of genes involved in fatty acid oxidation 
Figure 3.14: Relative expression of genes involved in fatty acid oxidation in the liver. Differences in gene 
expression were analyzed using a one-way ANOVA test with multiple comparison (Uncorrected Fisher’s LCD) 
of the mean of each experimental group. Different letters denote statistical significance (p < 0.05) between the 
mean of the groups. The results are presented as mean ± SEM. To evaluate whether protein source or exercise had 
an impact on differences in relative gene expression, a two ways ANOVA was applied on the LF groups and 
statistical significance is highlighted and marked *.   
 
The relative expression of Ppar-α was lower in the mice fed LF diets than the mice fed HF/HS 
diets, independent of exercise. Figure 3.14 B illustrates that both diet and exercise are of 
importance in relation to the expression of Cpt2. The mice fed LF diets had significantly lower 
expression of Cpt2 than the sedentary mice fed HF/HS. In this group, exercise seemed to reduce 
the expression of Cpt2. Although results from one-way ANOVA demonstrated no difference 
between Sed and Ex group in the mice fed LF entrecôte, results from two-way ANOVA 
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indicates that exercise impact the expression of Cpt2 in the mice fed LF diets. The relative 
expression of Acox was lower in mice fed LF diets compared to mice fed HF/HS diets. In 
addition, the relative expression of Hmgcs2 was lower in the mice fed LF than in the mice fed 
HF/HS, with the exception of sedentary mice fed LF salmon. In this group, the expression of 
Hmgcs2 was not reduced compared to the exercised group fed HF/HS diet. Nevertheless, there 
was no effect of exercise in neither group on the expression of Acox or Hmgcs2. Analyzing the 
results with a two-way ANOVA indicates that protein source influence the expression of Acox 
and Hmgcs2, where mice fed LF salmon had a higher expression than mice fed LF entrecôte. 
 
Relative expression in the lipogenic regulator, Srebf1 and hepatic genes involved in 
inflammation and fibrosis as well as endocannabinoid regulated genes and genes involved in 
endocannabinoid metabolism were measured and are presented in Figure A.3-A.6 (Appendix 
VI).  
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4.0 DISCUSSION  
In this study, we demonstrate that a HF/HS diet based on casein, salmon and entrecôte as protein 
sources promote obesity and reduces insulin sensitivity severely compared to a diet with casein 
as the sole protein source. In agreement with an earlier study, these data suggest that various 
protein sources in a HF/HS diet have different effects on obesity development (Tastesen et al., 
2014). Furthermore, we show that a LF diet, exercise and the combination of these treatments 
have beneficial effects in reversing diet-induced obesity (DIO), regardless of protein source. 
Although a LF diet alone had a clear effect on glucose tolerance and the expression of genes 
involved in hepatic fat accumulation, the combination of a LF diet and exercise seems to have 
pronounced effect on weight loss, changes in body composition and insulin sensitivity. Thus, 
our results is in agreement with the finding that exercise and LF diets have great significance 
in the prevention of obesity-related metabolic disturbances (Vieira et al., 2009). In addition, our 
results are supported by other studies, which indicate that a LF diet seems to attenuate BW gain 
in obese mice (Jung et al., 2013) and that exercise improves insulin sensitivity in humans 
(Perseghin et al., 1996).  
 
4.1 Replacing casein with protein from salmon and entrecôte increase body weight 
and reduce glucose tolerance and insulin sensitivity  
The results from feeding experiment 1 demonstrates that replacement of salmon and entrecôte 
with casein in a HF/HS diet promotes weight gain, impair glucose tolerance and reduce insulin 
sensitivity, despite a similar energy intake. These results are supported by a previous 
unpublished study from our research group, where casein- fed mice had lower energy efficiency 
than mice fed chicken, cod or pork. Additionally, results from this study demonstrate that mice 
fed casein had a lower weight gain and an improved glucose tolerance and insulin sensitivity 
compared to mice fed pork. The beneficial effect of casein remains unknown; however, one 
possible explanation could be a reduced fat absorption. Casein in a HF background diet has 
previously been reported to cause a lower fat absorption compared with a HF diet with salmon 
(Ibrahim et al., 2011). Moreover, in a HF/HS diet, fat excretion is significantly higher in mice 
fed casein compared to mice fed pork, chicken and cod/scallop (Tastesen et al., 2014). Our 
results are in accordance with the previous mentioned study, which indicates that fat absorption 
is higher in mice fed mixed proteins from meat, fish and casein compared to mice fed solely 
casein. Hence, the elevated fat absorption may further reflect a higher weight gain as 
demonstrated in our experiment. These findings indicate that casein may not be the most 
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suitable protein source to use if we want to induce obesity. However, another study comparing 
different fish proteins with casein showed that body weight gain was significantly lower and 
insulin sensitivity was improved in rats fed salmon proteins compared with rats fed casein 
(Pilon et al., 2011). Nevertheless, these findings were not confirmed in our experiment, and 
possible explanations may be that the amount of salmon protein (1/3) was lower in our diet, or 
that there appears to be differences in fat absorption between mice and rats. Thus, the 
contradicting findings related to weight gain and insulin sensitivity indicate that there might be 
other factors than fat absorption and feed efficiency, which can explain these differences. 
 
4.2 Exercise and low fat diets with salmon or entrecôte reduces body weight and 
improves body composition in obese C57BL/6J mice 
4.2.1 The effect of exercise and a low fat diet on body weight development 
Although we did not see any significant difference in BW development between mice fed LF 
salmon and LF entrecôte during seven weeks of feeding, differences were evident between mice 
fed LF and HF/HS diets. These results are supported by Vieira et al., who demonstrated that 
after six weeks on a HF diet, both a LF diet and exercise seemed to attenuate BW gain, but a 
LF diet had a more pronounced effect (Vieira et al., 2009). These results are further in 
accordance with a study done with humans, which demonstrated significant weight loss by 
dieting, but not by exercise (Stefanick et al., 1998). Moreover, evaluating BW change, our 
results indicate that exercise is of greater importance in the mice fed LF than in the mice fed 
HF/HS. Nevertheless, it is reasonable to believe that this difference is a result of a significantly 
higher activity level and lower energy intake in the mice fed LF diets. Another possible additive 
factor could be the impact of an elevated amount of sucrose in the HF/HS diet, as increased 
amounts of sucrose dose-dependently increase energy efficiency and WAT mass (Hao et al., 
2012). Nevertheless, whether the impact of dietary sucrose has the ability to suppress the effect 
of exercise is only speculation, and needs to be further investigated.  
 
4.2.2 The effect of protein source on fat digestibility  
BW change, energy intake and feed efficiency was not significantly different in mice fed 
salmon and mice fed entrecôte, and for this reason we did not expect to see great variations in 
apparent fat digestibility. Surprisingly, our results demonstrated that fecal excretion of fat was 
significantly higher in the mice fed entrecôte compared to the mice fed salmon. In spite of 
unexpected results, this finding is in accordance with an unpublished study from our research 
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group, which demonstrated that in a western diet, seafood- fed mice had a higher apparent fat 
absorption than mice fed meat. The reason for these differences in fat absorption remains 
unknown; however, it is tempting to believe that the composition of FAs in the diet (Table A.4, 
appendix II) may be of importance, as the LF salmon diet consists of more n-3 FAs than the LF 
entrecôte diet and the content of SFAs is higher in the LF entrecôte diet. Thus, this needs to be 
further investigated.    
 
4.2.3 The effect of low a fat diet and exercise on fat mass, lean mass and WAT depots 
Although mice fed LF entrecôte had a lower fat digestibility than mice fed LF salmon, this was 
not reflected in fat mass or fat depots. The effect of a LF diet on fat mass was still of great 
significance, independent of protein source or exercise. This finding is somewhat inconsistent 
with previous studies, which conclude that exercise have important benefits compared to diet 
alone (Tsai et al., 2003, Vieira et al., 2009). As there was no significant difference between Sed 
and Ex group fed HF/HS, and as the sedentary mice fed LF had a significantly reduced BW 
compared to the mice fed HF/HS Ex, we cannot support this statement. It is however reasonable 
to believe that the contradicting results may be due to differences in physical activity in our 
study, as mice fed HF/HS had a significantly lower physical activity than mice fed LF diets. In 
the previously mentioned studies, the various groups had the same level of physical activity, 
regardless of diet.  
 
The impact of exercise does, however, seem to have important benefits compared to diet alone 
in the mice fed LF when evaluating the weight of eWAT. The only groups with lower eWAT 
mass than the mice fed HF/HS were mice assigned to exercise. The finding that exercise reduces 
eWAT weight is consistent with findings from Vieira et al. (2009). The observed effect of 
exercise was, however, not evident in the mice fed HF/HS in our experiment. Contrarily, in a 
study conducted by Linden et al., the impact of exercise in a very high fat (VHF) diet on eWAT 
weight was clearly demonstrated (Linden et al., 2014). This could indicate that the amount of 
dietary sucrose is of importance in regards to eWAT weight, as high amounts of sucrose in the 
diet is associated with a higher weight of WAT (Hao et al., 2012). Nevertheless, we should not 
ignore the fact that the mice fed HF/HS diet had a low activity level compared to the mice fed 
LF diet. The same trend was not observed when evaluating iWAT mass, suggesting that a LF 
diet alone or a combination of a LF diet and exercise seems to determine the weight of iWAT. 
Investigating the micrographs of iWAT indicate that both a LF diet and exercise has the ability 
to reduce the size of lipid droplets in iWAT.  
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The change in lean mass from week 0-5 was significantly increased in the mice fed LF 
compared to the mice fed HF/HS diet. This finding suggests that both LF diets alone and in 
combination with exercise are of great importance to maintain lean mass, independent of protein 
source. The effectivity of a combined treatment (LF diet and exercise) on preserving lean mass 
is supported by a study done in humans (Rice et al., 1999). We hypothesized that the increase 
in lean mass would be greater in the Ex group than the Sed group due to a possible higher 
muscle mass, at least in the mice fed LF. This hypothesis was rejected, as the weight of both m. 
gastrocnemius and m. tibialis anterior did not differ in either group. Nevertheless, as the BW 
was significantly lower in the mice fed LF compared to the mice fed HF/HS diets and, the 
relative muscle mass is higher in the mice fed LF, this suggests that the mice fed LF diets 
preserves muscle mass better than the mice fed HF/HS. However, our results indicate that the 
effect of exercise on lean mass was greater in the mice fed entrecôte than the mice fed salmon. 
The reason for this remains unknown, but the same trend was observed in BW change and fat 
mass change in this group. As expected, combining exercise with a LF diet was of greater 
significance on fat reduction and maintenance of lean mass than either treatment alone. These 
findings further support the Norwegian national guidelines, which suggests daily amounts of 
exercise and a intake of saturated fat below 10 E% (Helsedirektoratet, 2014).   
 
4.2.4 The importance of a low fat diet and exercise on UCP1 expression in iBAT 
Although fat absorption was significantly higher in mice fed LF salmon than in mice fed LF 
entrecôte, this was not reflected in BW nor WAT mass. Hence, we hypothesized that the absent 
increase in BW or WAT mass in mice fed LF salmon could be explained by an increased energy 
expenditure through the expression of UCP1 in iBAT. However, this hypothesis was rejected, 
as there was no statistical difference between neither iBAT weight nor expression of UCP1 in 
mice fed LF salmon and LF entrecôte. Moreover, micrographs of iBAT in any group 
demonstrated that most of the brown adipose organ consisted of unilocular cells, with a greater 
diameter in the mice fed HF/HS than the mice fed LF diets. This finding was not surprising, 
considering that BAT in obese mice is characterized by small, unilocular, UCP1-positive brown 
adipocytes (Cinti et al., 1997). The abnormal morphology of iBAT in obese mice is most likely 
attributable to a low sympathetic stimulation of iBAT (Himms-Hagen, 1989). Furthermore, the 
low sympathetic stimulation is possibly caused by a defect in the receptor-signaling pathway 
for leptin within the hypothalamus (Chen et al., 1996, Chua et al., 1996). Surprisingly, although 
the size of brown adipocytes were smaller with a LF diet and exercise, the morphology of BAT 
still mostly consisted of small, unilocular, brown adipocytes, more similar to that of WAT. We 
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expected that switching to a LF diet or being subjected to exercise would give iBAT back its 
phenotypic characteristics, namely the multilocular adipocytes. This was, however, not the case 
and our results suggest that the reverse effect of a LF diet, exercise or protein source on iBAT 
in obese mice fed a HF/HS diet is not of great significance. Whether the outcome would have 
been different if the mice had been given a LF diet or exercised over a longer period needs to 
be further investigated. Moreover, another interesting approach would be to evaluate 
micrographs from iWAT to quantify expression of UCP1, as it has been proposed that exercise 
induce browning of subcutaneous adipose tissue (Bostrom et al., 2012). It is hypothesized that 
the impact of exercise may be explained by metabolites derived from PGC1-α, including the 
hormone irisin and β-Aminoisobutyric Acid, which both has the ability to stimulate the 
expression of UCP1 and other thermogenic genes within WAT (Huh et al., 2012, Roberts et al., 
2014). 
 
Although not that obvious, our results suggest that a LF diet, exercise and the combination of 
these factors affect the size of the brown adipocytes and the expression of UCP1 in iBAT. The 
reduced mass of iBAT in the mice fed LF diet is most likely due to a decreased adipocyte size. 
A study conducted by De Matteis et al., demonstrated that exercise made the lipid droplets in 
brown adipocytes shrink, which is in accordance with our findings (De Matteis et al., 2013). 
Our results further indicate that exercise promote a higher expression of UCP1, predominantly 
in the mice fed LF salmon. The beneficial effects of exercise on brown adipocytes are poorly 
understood; however, it is reasonable to believe that the hormone irisin is responsible for some 
of the beneficial effects seen with exercise (Bostrom et al., 2012). Irisin is regulated by PGC1α, 
which is secreted from muscle to blood, and has the ability to activate thermogenic functions in 
adipose tissue, including elevation of UCP1. This hypothesis is further supported by the fact 
that rats subjected to exercise had an elevated expression of Ppargc1a and reduced expression 
of Ppargc1b (De Matteis et al., 2013). Moreover, the expression of MCT-1 was elevated in 
iBAT of rats assigned to exercise. MCT-1 has recently been detected in iBAT and functions as 
a transporter for lactate across the plasma membrane (Iwanaga et al., 2009). Lactate is used by 
BAT as a lipogenic substrate (Saggerson et al., 1988) and is considered the major gluconeogenic 
precursor in rats exposed to exercise (Brooks and Donovan, 1983, Donovan and Brooks, 1983). 
Hence, it is hypothesized that increased metabolic activity in iBAT induced by exercise may be 
related to lactate uptake, as these mice had a higher expression of MCT-1 in brown adipocytes 
(De Matteis et al., 2013). However, other explanations for elevated expression of MCT-1 is 
possible, so this needs further investigation.  
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4.3 The effect of a low fat diet and exercise on glucose homeostasis 
4.3.1 The importance of low fat diet is evident in relation to glucose tolerance 
Our results demonstrate a clear effect of LF diet in reducing fasting plasma glucose levels and 
exercise does not seem to improve blood glucose further. These results are supported by other 
similar experiments done in mice, demonstrating that a switch to LF diet reduced plasma 
glucose levels to near-euglycemia, and significantly improved glucose tolerance (Jung et al., 
2013, Linden et al., 2014). Consistent with other studies (Muurling et al., 2002, Vieira et al., 
2009), our results further suggest that a LF diet decrease the level of fasting insulin in plasma. 
Although the method for measuring insulin levels was not the same in the study by Jung et al 
(2013), similar observations were made in fasted state, which indicates that a LF diet is more 
effective in improving glucose tolerance than exercise. Furthermore, these data suggest that 
metabolic abnormalities induced by HF/HS feeding are reversible upon withdrawal of HF/HS 
diet. The pathogenesis of obesity- mediated insulin resistance has lately been linked to adipose 
tissue inflammation (Weisberg et al., 2003, Wellen and Hotamisligil, 2005), as circulating 
cytokines may negatively affect the insulin signaling pathway (Linden et al., 2014). However, 
another possible explanation may be due to inflammation in other tissues, including the liver, 
as weight loss has an obvious effect to attenuate hepatic inflammation (Jung et al., 2013). The 
reversible effect on hepatic inflammation was associated with lower basal glucose production 
and a significant improvement in hepatic insulin resistance. The elusive effect of exercise on 
glucose tolerance in our study may possibly be reflected in the latter study, as in this study, 
hepatic insulin action was greatly enhanced in the mice submitted to a LF diet but not in the 
mice submitted to exercise, they remained hepatic insulin resistant. Furthermore, diets high in 
saturated fat have been shown to directly induce WAT inflammation (Vieira et al., 2009), and 
this may explain the observed independent effect of LF diet on glucose tolerance. 
   
4.3.2 The importance of diet, exercise and possible protein source on insulin sensitivity  
Our findings from ITT indicates that insulin sensitivity is more affected by exercise than what 
glucose tolerance is. Area over the curve was calculated to see how the mice responded to 
insulin infusion during ITT. The decrease in blood glucose was higher in the mice submitted to 
exercise, regardless of diet, indicating a better response to insulin in these animals. However, a 
diet effect was also observed, whereas the mice fed LF responded better to insulin than the mice 
fed HF/HS. Our findings are consistent with the statement that a LF diet and/or exercise cause 
a dramatic improvement in whole body insulin sensitivity in obese mice (Jung et al., 2013). 
This is further supported in humans, as physical training increased insulin sensitivity in both 
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patients with impaired insulin sensitivity and normal subjects (Perseghin et al., 1996). The 
improved insulin sensitivity was explained by a stimulation of insulin mediated muscle 
glycogen synthesis as well as a reversal of a defect in insulin- stimulated glucose transport- 
phosphorylation. This explanation is consistent with the fact that one bout of exercise seemed 
to increase postprandial muscle glycogen synthesis more than threefold in insulin resistant 
subjects (Rabol et al., 2011). As exercise did not seem to affect changes in hepatic glycogen 
synthesis in these subjects, it is reasonable to believe that muscle insulin resistance precedes 
hepatic insulin resistance and that muscle insulin resistance causes postprandial increase in net 
hepatic triglyceride synthesis, which potentially leads to NAFLD. Thus, the advantageous 
effect of exercise on insulin sensitivity could be attributable to improved muscle glucose 
metabolism, as skeletal muscle in mice fed LF diet remained insulin resistant compared to the 
mice submitted to exercise (Jung et al., 2013). Furthermore, in our experiment, the reduction of 
WAT size seems to be influenced by exercise, and could possibly be explained by reduced 
inflammation in WAT (Vieira et al., 2009). In addition, other mechanisms in which exercise 
may reduce WAT inflammation could be increased blood flow, increased mitochondrial 
function and facilitated FA oxidation. It is plausible that an increased blood flow to WAT 
mediated by exercise would ameliorate inflammation by decreasing hypoxia, which is 
implicated to be a cause of adipose tissue inflammation in obesity (Ye, 2009). However, our 
results also demonstrate that a LF diet alone has an effect of improving insulin sensitivity, 
although the effect is greater combined with exercise. Improved insulin sensitivity following 
weight loss with a LF diet may be associated with reduced content of lipids in the liver (Jung 
et al., 2013). A possible explanation for this might be that ectopic lipid accumulation and 
increased levels of intracellular lipid derived metabolites induces hepatic insulin resistance 
(Kim et al., 2001). Our results from qPCR supports this statement, as for the most part, genes 
involved in fat accumulation were suppressed in the liver of mice receiving LF diets.  
 
4.4 The expression of genes involved in fat accumulation and fatty acid oxidation 
LF diets alone or combined with exercise resulted in a significantly lower liver weight, and 
micrographs indicates that the elevated liver weight in the mice fed HF/HS is due to hepatic 
lipid accumulation. This is further compatible with the fact that expression of genes involved 
in lipid synthesis and FA uptake were mostly lower in the mice fed LF diets, and the 
significance of exercise was not evident evaluating the micrographs. In our experiment, exercise 
was of minor importance for regulation of the expression of genes that was measured. One 
exception was, however, Fasn, where exercised mice fed HF/HS diet had a lower expression 
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than the sedentary mice fed HF/HS diet. However, in the mice fed LF diets, protein source 
seemed in some degree to determine the expression of certain genes. Scd1 (involved in lipid 
synthesis) had reduced expression in the mice fed LF salmon than the mice fed LF entrecôte. 
The differential effect is most likely linked to the different n-3/n-6 PUFA ratio in salmon and 
entrecôte, as the ability to suppress expression of genes involved in lipogenesis is a hallmark of 
fish oil and n-3 PUFAs (Jump et al., 2005). Furthermore, it is reported that in the liver of mice 
fed a Western diet with salmon as protein source, levels of steorylethanolamide (SEA) were 
elevated (Midtbo et al., 2015), and administration of SEA is accompanied with down regulation 
of Scd1 (Terrazzino et al., 2004). Thus, the lowered expression of Scd1 may be attributable to 
elevated levels of SEA, though we did not measure this in our experiment. In addition, it is 
suggested that n-3 PUFAs reduce hepatic lipid accumulation through increased FA oxidation 
and suppressed TAG formation (Madsen et al., 1998, Rossmeisl et al., 2014). Our findings 
support this, as the expression of both Acox and Hmgcs2 (involved in FA oxidation) was 
elevated in the mice fed salmon compared to the mice fed entrecôte. In light of the beneficial 
effects of n-3 PUFA on hepatic lipid accumulation, we expected to see the same pattern in the 
other genes we tested. Nevertheless, expression of Cd 36 (involved in FA uptake) was lower in 
the mice fed entrecôte than the mice fed salmon, and in the remaining genes involved in fat 
accumulation and FA oxidation, there were no difference between the different protein sources. 
A possible explanation for the unexpected results may be the altered n-3/n-6 ratio of the salmon 
used in our experiment, which is illustrated in Figure A.1 (Appendix II). Recent research 
indicates that a reduced ratio of n-3/n-6 PUFA in the fish feed, reflected in the salmon and thus 
also in the mice subjected to this salmon in the diets, led to a diet- induced accumulation of 
lipids in the liver (Midtbo et al., 2015). Although the amount of n-3 PUFAs is higher in the LF 
salmon diet than LF entrecôte, it is possible that the level of n-3 PUFAs is not high enough to 
identify differences in the expression of certain genes. This is in accordance with the fact that 
mice exposed to a diet with salmon fed soy- oil and mice fed chicken had a higher expression 
of genes involved in FA uptake and synthesis compared with mice exposed to salmon fed fish-
oil (Midtbo et al., 2015). Thus, an altered n-3/n-6 ratio seems to be of importance due to lipid 
accumulation in the liver and may possibly explain the expected differences we did not see 
between salmon and entrecôte.   
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4.5 Experimental considerations  
Although the activity in brown adipocytes and the expression of their hallmark genes are highly 
influenced by a low temperature, our experiment was conducted under thermoneutral conditions 
(29.3 ± 0.4 °C). Some may argue that the effect of BAT will disappear when temperature is 
high; however, a lower room temperature causes chronic thermal stress to mice, which increase 
their metabolism to defend body temperature. Hence, in order to evaluate if there was an effect 
of exercise, diet and protein sources on the expression of UCP1, without influence from thermal 
stress, mice were kept at thermoneutrality. Furthermore, the mice in Ex- groups were assigned 
a running wheel, making exercise voluntarily. The drawback by voluntarily exercise is that we 
cannot control the level of physical activity, and there might be great individual differences. 
However, voluntarily exercise is more convenient by the fact that it is not forced and we have 
the ability to evaluate whether exercise has an effect on diet and vice versa. Moreover, in our 
experiment, we had wireless running wheels that detected the level of physical activity and we 
were thus able to reveal activity level in the different groups. In terms of testing, prior to ITT, 
we did not remove the running wheels from Ex groups. This makes it hard to distinguish 
whether the impact of exercise seen in our results is caused by an acute or a long-term effect of 
exercise. Nevertheless, there is no certainty that the result had been different if we did remove 
it.    
 
4.5.1 The animal model and relevance to humans    
In nutritional research, mice are the most commonly animal model used because of their genetic 
and physiological similarity to humans. Nevertheless, mice used for research are usually inbred 
strains with less genetic variation than humans. It is important that the characteristics of a 
specific strain is not considered general, but as a unique feature for the current strain. The 
animal model studied in our experiment (C57BL/6J) was used because of its ability to develop 
DIO, hyperinsulinemia and hyperglycemia (Black et al., 1998). Hence, this specific strain 
stands out as a representative model to elucidate the pathophysiology of an obesity syndrome 
similar to that in humans. The Norwegian health authorities recommends increased physical 
activity, as well as specific amounts of carbohydrates in which added sugar should not exceed 
10 E % and fat should not exceed 40 E %. In the present study, we have demonstrated that 
increased physical activity and reduced amount of fat and added sugar in the diet (8 E %) is 
beneficial regarding weight loss, supporting the recommendations from National guidelines. 
The recommendations do however not specify anything about different type of proteins. Our 
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results supports this, as the protein source in a LF diet did in general not seem to give different 
effects on DIO. Although the results from our study are in accordance with national guidelines, 
the same type of study needs to be carried out in humans before we can conclude that they have 
human relevance.      
  
4.6 Future perspectives  
The impact of diet and/or exercise has gained much attention lately as a method for weight 
regulation. Controversial, some individuals claim that they do not lose weight despite increased 
physical activity, while others seem to have great benefits from it. The present study 
demonstrated that in mice fed HF/HS, treatment of DIO was not affected by exercise. In future 
studies, it would be interesting to investigate if the absent effect of exercise could be attributable 
to the amount of sucrose in the diet, and if the impact of exercise is modified if we replace 
sucrose with other carbohydrate sources. Although our results illustrated that the mice fed 
HF/HS diet had a lower level of physical activity, the basis for this hypothesis is that in mice 
fed a VHF diet, exercise seemed to be of great importance considering BW development, 
eWAT weight and fasting plasma insulin levels (Linden et al., 2014). Furthermore, a possible 
next step for this study could be to evaluate the importance of time perspective in a diet and/or 
exercise intervention.  
In future studies it could also be of interest to reveal explanation for the differences we assessed 
in fat digestibility between mice fed salmon and entrecôte. Analyses of FA composition in feces 
would be of interest, to evaluate if some FAs are more easily excreted than others are. It would 
further be intriguing to explore the effects of gut bacteria on nutrient absorption and excretion 
in diets with different protein sources. Moreover, as salmon and entrecôte seemed to give 
various effect on hepatic gene expression, it would have been interesting to see if this reflected 
the protein level, by applying a method such as western blot.   
Another further approach would be to investigate the effect of exercise on expression of UCP1 
in iWAT, as the expression was not clearly pronounced in iBAT and a recently published study 
suggest that exercise may induce beige adipocytes in WAT, possibly attributed to the hormone 
irisin. Therefore, it would be of interest to measure levels of irisin in plasma.  
Lastly, it would be of particular importance to explore if the findings in this animal experiment 
could be mimicked in humans.  
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5.0 CONCLUSION  
 
The present study present following findings: 
 
- Mixture of proteins from casein, salmon and entrecôte in a high fat – high sucrose diet 
promotes obesity and reduces insulin sensitivity significantly compared to a 100% 
casein based high fat – high sucrose diet.  
- Combination of exercise and low fat diet with either salmon or entrecôte have beneficial 
effects on weight loss and changes in body composition. 
- A low fat diet improves glucose tolerance alone and insulin sensitivity is further 
improved by exercise. The importance of protein source in a low fat diet in relation to 
glucose homeostasis is not significant.  
- The effect of a low fat diet is clear regarding the expression of genes involved in hepatic 
fat accumulation, where mice fed low fat diet with salmon seemed to have some benefit 
over mice fed low fat with entrecôte evaluating the expression of genes involved in fatty 
acid oxidation. The impact of exercise was however not evident in most genes we 
measured.  
 
Although the results from this animal experiment cannot be directly linked to human nutrition, 
our findings suggest that a combination of a low fat diet and exercise is of great significance in 
reversing diet induced obesity and impaired insulin sensitivity, and that overall, salmon and 
entrecôte exerts the same beneficial effects in a low fat diet. Our results is in accordance with 
national guidelines; however, further research will be needed to explore these findings in human 
nutrition.   
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APPENDIX 
APPENDIX I – Diets  
Table A.1: Diet composition in LF acclimatization diet (ssniff EF R/M Control) 
Crude nutrients % 
Dry matter 95.2 
Crude protein 20.8 
Crude fat 4.2 
Crude fibre 5 
Crude Ash  5.6 
N free extracts 59.4 
Starch  46.8 
Sugar 10.8 
Energy (kJ/g) 18 
 
Table A.2: Diet composition and analyzed nutrients in the animal experiment (g/kg)  
 
Table A.3: Analyzed nutrients in the protein source 
(g/100g) Salmon Entrecôte  
Crude fat 43.24 30.29 
Crude protein 50.63 63.31 
Low fat diets was balanced in fat amount by adding corn oil.  
Group HF/HS Low fat  Low fat 
(g/kg) Protein Protein Protein  
Ingredients Salmon + entrecôte Salmon Entrecôte 
Entrecôte 111.1                       - 145.9 
Salmon 138.6 178.2                      -  
Casein 70.0 103.6 103.6 
L-cystein  3 3 3 
Starch(normal) 9.5                       -                      - 
Sucrose (melis) 410.5 91.8 91.8 
Cellulose 50 50 50 
Dextrin 10 524 524 
Corn oil 150 2.10 36.7 
t-butyl 0.02 0.02 0.02 
Mineral mix 35 35 35 
Vitamin mix 10 10 10 
Cholin  2.5 2.5 2.5 
Sum 1000 1000 1003 
  Analyzed    
(g/100 g)     
Fat  24.9 8.4 8.4 
Protein 21.8 17.3 17.3 
Energy (kJ/g) 23.1 18.4 18.3 
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Appendix II – Fatty acid analyses  
 
Table A.4: Analyzed fatty acid (FA) composition in the experimental LF - diets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1: Percentage distribution of n-6 and n-3 FAs in the LF- diet.  
 
 
 
FAs in diet Protein Protein 
(mg/g) Salmon Entrecôte  
Sum SFA 11.15 28.48 
Sum MUFA 42.46 26.09 
Sum PUFA 24.73 21.03 
LA: 18:2n-6 12.45 19.84 
AA: 20:4n-6 0.46 0.13 
Sum n-6 14.21 20.05 
ALA: 18:3n-3 3.89 0.45 
EPA: 20:5n-3 1.68 0.02 
DHA: 22:6n-3 2.64 0.00 
Sum n-3 10.40 0.77 
n-3/n-6 ratio 0.73 0.04 
AA/EPA ratio  0.27 6.03 
Sum identified 78.34 75.60 
Sum unidentified  0.73 1.46 
Sum FA. 79.07 77.05 
(%)     
n-3 13.14 0.99 
n-6 17.97 26.61 
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Table A.5 Fatty acid composition in neutral lipids (NL) in LF- diets. 
Fatty acids in NL Protein Protein 
(mg/g) Salmon Entrecôte  
Sum SFA 11.31 23.37 
Sum MUFA 44.29 22.39 
Sum PUFA 24.73 19.72 
LA: 18:2n-6 12.93 18.92 
AA: 20:4n-6 0.45 0.01 
Sum n-6 14.73 18.96 
ALA: 18:3n-3 4.02 0.38 
EPA: 20:5n-3 1.57 0.00 
DHA: 22:6n-3 2.12 0.00 
Sum n-3 9.86 0.58 
n-3/n-6 ratio  0.67 0.03 
AA/EPA ratio  0.28 3.61 
Sum identified 80.33 65.48 
Sum unidentified  1.29 1.09 
Sum FA. 81.63 66.58 
(%)    
n-3 12,08 0.87 
n-6 18,05 28.52 
 
Table A.6: Fatty acid composition in phospholipids (PL) in LF diets.  
Fatty acids in PL Protein  Protein 
(mg/g) Salmon  Entrecôte  
    
Sum SFA 0.57  0.92 
Sum MUFA 0.97  0.80 
Sum PUFA 1.53  0.88 
LA: 18:2n-6 0.30  0.69 
AA: 20:4n-6 0.04  0.08 
Sum n-6 0.39  0.80 
ALA: 18:3n-3 0.12  0.03 
EPA: 20:5n-3 0.21  0.01 
DHA: 22:6n-3 0.67  0.00 
Sum n-3 1.13  0.08 
n-6/n-3 ratio 2.90  0.11 
AA/EPA ratio  0.18  6.00 
Sum identified 3.06  2.61 
Sum unidentified  0.04  0.20 
Sum FA. 3.11  2.81 
(%)     
n-3 36.54  3.09 
n-6 12.62  28.98 
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Appendix III – Amino acid analyses  
 
Table A.7: Amino acid composition in LF diets 
Amino acids Protein Protein  
(mg/g) LF Salmon LF Entrecôte  
Histidine  4.86 5.09 
Serine  8.26 7.94 
Arginine 8.14 7.87 
Glycine 5.70 5.09 
Aspargine 16.15 13.99 
Glutamine 33.76 33.49 
Threonine  8.00 7.26 
Alanine  7.95 6.87 
Proline 13.15 13.31 
Lysine 15.51 13.64 
Tyrosine  6.92 6.83 
Methionine  6.12 5.92 
Valine  10.97 9.84 
Isoleucine  8.52 7.87 
Leucine 15.52 14.64 
Phenylalanine 8.78 8.43 
Sum essential AA 73.41 67.59 
Sum non-essential Aas 104.89 100.47 
Sum BCAAs 35.01 32.34 
Total 178.30 168.07 
Hydroxyprolin* 0.14 0.37 
Taurine* 0.14 0.00 
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Appendix IV Histology 
 
Table A.8 Reagents and time schedule for each step in the dehydration process. 
Reagent  Time (min) Vendor 
50% EtOH 45  Arcus Kjemi. Norway 
75% EtOH 45 Arcus Kjemi. Norway 
95% EtOH 45 x 2 Arcus Kjemi. Norway 
100% EtOH 45 x 3 Arcus Kjemi. Norway 
Xylene 45 x 2 Prolabo 
Paraffin Overnight Histovax. OneMed  
Paraffin 15 x 2 Histovax. OneMed  
 
 
Table A.9: Reagents and time schedule for each step in the rehydration, staining and dehydration 
process.  
Reagent Time (min) Vendor 
Xylene 2 x 10  Prolabo  
100% EtOH 2 x 10  Arcus Kjemi. Norway 
95% EtOH 2 x 5 Arcus Kjemi. Norway 
75% EtOH 5  Arcus Kjemi. Norway 
50% EtOH 5 Arcus Kjemi. Norway 
ddH2O 5 MilliQ Biocel. USA  
Hematoxylin 2  EMS  
H2O Wash  
Eosin 30 sek Sigma. USA 
H2O Wash  
ddH2O 1  MilliQ Biocel. USA  
50% EtOH 2 Arcus Kjemi. Norway 
75% EtOH 2  Arcus Kjemi. Norway  
95% EtOH 2 x 2 Arcus Kjemi. Norway 
100% EtOH 2 x 5  Arcus Kjemi. Norway 
Xylene 2 x 5 Prolabo 
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APPENDIX V – Immunohistochemistry  
 
Table A.10: Time and reagents used in the rehydration process 
 
Table A.11: Time schedule and reagents used in the dehydration process.  
 
 
Table A.12: Solutions and reagents used in the immunohistochemistry process  
Solution 
 
Contents 
PBS buffer 1000 ml ddH2O + 5 tablets Phosphate Buffered Saline (SIGMA P4417) 
Citrate buffer 
 
Tri – Sodium citrate dehydrate + ddH2O 
3% H2O2 in MetOH 
 
3% H2O2  + MetOH (SIGMA, Lot #SZBD142SV) 
PBS + 0,1% Tween 
 
PBS + Technical Tween 20 (Product 28829.296, VWR) 
Serum 
 
Vectastain, Goat, normal serum (VECTOR laboratories) 
Primary antibody 
 
Anti UCP1 (C4/98), recieved from Prof Jan Kopecky and Dr. Pavel 
Flachs 
Secondary antibody  
 
PBS buffer + Vectastain, Anti-rabbit IgG, antibody (VECTOR 
laboratories) 
ABC 
 
PBS buffer + 2 drops vectastain ABC reagent A + 2 drops vectastain 
ABC reagent B + H2O2 
DAB 
 
5 ml ddH20 + 2 drops buffer stock + 4 drops DAB stock solution + 2 
drops H2O2 solution 
Reagent  Time  
Xylene  15 min 
100% EtOH 2 x 5 min  
95% EtOH 5 min 
75% EtOH 5 min 
50% EtOH 5 min  
ddH2O 2 x 5 min  
Reagent  Time  
50% EtOH 10 min  
75% EtOH 10 min  
95% EtOH 10 min  
100% EtOH 10 sec 
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Figure A.2: Immunohistological expression of UCP1 in mice fed HF/HP diet (A) and mice fed 
HF/HP exposed to cold (B). 
 
APPENDIX VI – Real time qPCR 
 
Table A.13: RT reaction mix for a 50 µl RT reaction   
  Reagents  50 µl  
Final 
concentration  
 
Vendor 
 
Non enzymatic 
reagents H2O 890   
Applied 
biosystems 
 
  10x TaqMan RT buffer 500 1 X 
Applied 
biosystems 
 
  25 mM MgCl2 1100 5.5 mM 
Applied 
biosystems 
 
  
10 mM deoxyNTPs  
Mixture (2,5 mM of each dNTP)     1000 
500 µM per 
dNTP 
Applied 
biosystems 
 
  50 µM Random hexamers 250 2.5 µM 
Applied 
biosystems 
 
Enzymes Rnase Inhibitor (20 U/µl) 100 0.4 U/µl 
Applied 
biosystems 
 
  
Multiscribe Reverse 
Transcriptase (50 U/µl) 167 1.67 U/µl 
Applied 
biosystems 
 
 
 
Table A.14: Instrument setup for Reverse Transcription    
Step Incubation  RT 
Reverse Transcription 
Inactivation  End  
  HOLD HOLD HOLD HOLD 
Temperature (°C) 25 48 95 4 
Time (minutes) 10 60 5 ∞* 
Volume (µl)          50   
 
 
 
 
 
HF/HP HF/HP Cold exposed  
A                                                            B       
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Table A.15 Primers used for qPCR  
Oligo name Sequence (5’ to 3’) 
Aars Forward GGAGGAACACATCTACGGAA 
Aars reverse  CTGTGACAGCAACAATCCTC 
Acc1 Forward TGCTGCCCCATCCCCGGG 
Acc1 Reverse  TCGAACTCTCACTGACACG 
Acox Forward GGGTCATGGAACTCATCTTCGA 
Acox reverse GAATGAACTCTTGGGTCTTGGG 
Adrp Forward  ACAAGTGCCCTGCCCATC 
Adrp Reverse  GGCAACCGCAATTTGTGG 
Asns Forward  CCAACCGGTCTTGTCACT 
Asns Reverse  CAGGCACTCTGAGCACTA 
Cd 36 Forward  AATTAGAACCGGGCCACGTA 
Cd 36 Reverse CGCCAACTCCCAGGTACAA 
Cnr2 Forward ACGGTGGCTTGGAGTTCAAC 
Cnr2 Reverse  ACGGTGGCTTGGAGTTCAAC 
Cola1 Forward  GCTCCTCTTAGGGGCCACT 
Cola1 Reverse CCACGTCTCACCATTGGGG 
Cpt2 Forward  AGCCTGCCCAGGCTGCC 
Cpt2 Reverse  AAACCAGGGGCCCTGAGATG 
Faah Forward  CCTGGAGACCATGGACAA 
Faah reverse  GTCAGGATTCTGCAGCCG 
Fabp1 Forward GGAATTGGGAGTAGGAAGAGCC 
Fabp1 Reverse TGGACTTGAACCAAGGAGTCAT 
Fasn Forward CTTCGCCAACTCTACCATGG 
Fasn Reverse TTCCACACCCATGAGCGAGT 
Hmgcs2 Forward  AGCCCAGCAGAGGTTTTCTACAA 
Hmgcs2 Reverse  CATACGGGTCTGGCCCAAG 
Insig1 Forward CTGTATTGCCGTGTTCGTTG 
Insig1 Reverse CTTCGGGAACGATCAAATGT 
Lpin1 Forward AAGAGACTGACAACGATCAGGA 
Lpin1 Reverse AAGAGACTGACAACGATCAGGA 
Lpin2 Forward TCCACCAAGGTCACCAAAAG 
Lpin2 Reverse GGGCTCTAGGTTTGGGTTTC 
Mgll Forward  CAGACGGACAGTACCTCTTT 
Mgll Reverse  ACAAAGATGAGGGCCTTGG 
Mmp-2 Forward TTTGCTCGGGCCTTAAAAGTAT 
Mmp-2 Reverse  CCATCAAATGGGTATCCATCTC 
Mmp-9 Forward  GGACCCGAAGCGGACATT 
Mmp-9 Reverse  CCTTGCCGTCGAAGGGATA  
Ppar-α Forward CGTTTGTGGCTGGTCAAGTT 
Ppar-α Reverse AGAGAGGACAGATGGGGCTC 
Psat1 Forward GTGCTCGAAATGAGTCACAG 
Psat1 Reverse  AGCTAGCAATTCCCTCACAA 
Scd1 Forward GATGTTCCAGAGGAGGTACTACAAGC 
Scd 1 Reverse  ATGAAGCACATCAGCAGGAGG  
Srebf1 Forward GGAGCCATGGATTGCACATT 
Srebf1 Reverse GCTTCCAGAGAGGAGCCCAG 
Tgfb1 forward  AGCAGTGCCCGAACCCCCAT 
Tgfb1 reverse  GGGGTCAGCAGCCGGTTACC 
Tnf-a forward CCCTCACACTCAGATCATCTT 
Tnf-a reverse  GCTACGACGTGGGCTACAG 
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Figure A.3: Relative expression of the lipogenic regulator Srebf1in the liver.  
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Figure A.4: Relative expression of endocannabinoid regulated genes in the liver. 
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Figure A.5: Relative expression of genes involved in hepatic inflammation, fibrosis and protease 
inhibitors.  
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Figure A.6: Relative expression of genes involved in hepatic endocannabinoid metabolism. 
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Appendix VII – Muscle mass  
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Figure A.7: Weight of m. gastrocnemius and m. tibialis anterior in the different groups.  
 
 
Appendix VIII ELISA Insulin Kit 
 
Table A.16: Reagents and equipment used in ELISA Insulin Kit 
Product name 
 
Vendor 
Insulin Mouse ELISA kit DRG Instruments GmbH, Germany 
Coated Plate  
Calibrator 0 (1 vial)  
Calibrators 1, 2, 3, 4 and 5 (5 vials)  
Enzyme Conjugate 11X (1 vial)  
Enzyme Conjugate Buffer (1 vial)  
Wash buffer 21X (1 bottle)  
Substrate TMB (1 bottle)  
Stop Solution (a vial)  
Adhesive PCR film AB-0558 Thermo Scientific  
 
 
